A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.
Unstable isotopes of iridium that decay or disintegrate emitting radiation. Ir atoms with atomic weights 182-190, 192, and 194-198 are radioactive iridium isotopes.
The total amount of radiation absorbed by tissues as a result of radiotherapy.
Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy.
Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES.
Unstable isotopes of ruthenium that decay or disintegrate emitting radiation. Ru atoms with atomic weights 93-95, 97, 103, and 105-108 are radioactive ruthenium isotopes.
Administration of the total dose of radiation (RADIATION DOSAGE) in parts, at timed intervals.
Tumors or cancer of the PROSTATE.
The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING.
The use of pre-treatment imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.
Tumors or cancer of the VAGINA.
Tumors or cancer of the UTERINE CERVIX.
High energy POSITRONS or ELECTRONS ejected from a disintegrating atomic nucleus.
Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes.
Computer systems or programs used in accurate computations for providing radiation dosage treatment to patients.
The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Ytterbium. An element of the rare earth family of metals. It has the atomic symbol Yb, atomic number 70, and atomic weight 173. Ytterbium has been used in lasers and as a portable x-ray source.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.
Tumors or cancer of the TONGUE.
Tumors of the choroid; most common intraocular tumors are malignant melanomas of the choroid. These usually occur after puberty and increase in incidence with advancing age. Most malignant melanomas of the uveal tract develop from benign melanomas (nevi).
A condition in which the death of adipose tissue results in neutral fats being split into fatty acids and glycerol.
The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv).
The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL.
Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
Minimally invasive procedures guided with the aid of magnetic resonance imaging to visualize tissue structures.
Inability to empty the URINARY BLADDER with voiding (URINATION).
Radiotherapy where there is improved dose homogeneity within the tumor and reduced dosage to uninvolved structures. The precise shaping of dose distribution is achieved via the use of computer-controlled multileaf collimators.
Organs which might be damaged during exposure to a toxin or to some form of therapy. It most frequently refers to healthy organs located in the radiation field during radiation therapy.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
A neoplasm containing HISTIOCYTES. Important forms include BENIGN FIBROUS HISTIOCYTOMA; and MALIGNANT FIBROUS HISTIOCYTOMA.
Tumors or cancer of the UVEA.
Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.
Unstable isotopes of strontium that decay or disintegrate spontaneously emitting radiation. Sr 80-83, 85, and 89-95 are radioactive strontium isotopes.
Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Surgical insertion of a prosthesis.
A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit.
Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; x-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.
Partial or total surgical excision of the tongue. (Dorland, 28th ed)
A subspecialty of medical oncology and radiology concerned with the radiotherapy of cancer.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Radiation protection, also known as radiation safety, is the science and practice of protecting people and the environment from harmful ionizing radiation exposure while allowing for the safe medical, industrial, and research uses of such radiation.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
Compounds which inhibit or antagonize the biosynthesis or actions of androgens.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
A segment of the COLON between the RECTUM and the descending colon.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Rhenium. A metal, atomic number 75, atomic weight 186.2, symbol Re. (Dorland, 28th ed)
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Devices or objects in various imaging techniques used to visualize or enhance visualization by simulating conditions encountered in the procedure. Phantoms are used very often in procedures employing or measuring x-irradiation or radioactive material to evaluate performance. Phantoms often have properties similar to human tissue. Water demonstrates absorbing properties similar to normal tissue, hence water-filled phantoms are used to map radiation levels. Phantoms are used also as teaching aids to simulate real conditions with x-ray or ultrasonic machines. (From Iturralde, Dictionary and Handbook of Nuclear Medicine and Clinical Imaging, 1990)
Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. (1/1081)

PURPOSE: To compare the prostate-specific antigen (PSA) relapse-free survival outcome and incidence of late toxicity for patients with early-stage prostate cancer treated at a single institution with either three-dimensional conformal radiotherapy (3D-CRT) or transperineal permanent implantation (TPI) with iodine-125 seeds. MATERIALS AND METHODS: Patients with favorable-risk prostate cancer, defined as a pretreatment PSA of less than or equal to 10.0 ng/mL, Gleason score of 6 or lower, and stage less than or equal to T2b, were selected for this analysis. Between 1989 and 1996, 137 such patients were treated with 3D-CRT and 145 with TPI. The median ages of the 3D-CRT and TPI groups were 68 years and 64 years, respectively. The median dose of 3D-CRT was 70.2 Gy, and the median implant dose was 150 Gy. Prostate-specific antigen relapse was defined according to the American Society of Therapeutic Radiation Oncology Consensus Statement, and toxicity was graded according to the Radiation Therapy Oncology Group morbidity scoring scale. The median follow-up times for the 3D-CRT and TPI groups were 36 and 24 months, respectively. RESULTS: Eleven patients (8%) in the 3D-CRT group and 12 patients (8%) in the TPI group developed a biochemical relapse. The 5-year PSA relapse-free survival rates for the 3D-CRT and the TPI groups were 88% and 82%, respectively (P = .09). Protracted grade 2 urinary symptoms were more prevalent among patients treated with TPI compared with 3D-CRT. Grade 2 urinary toxicity, which was manifest after the implant and persisted for more than 1 year after this procedure, was observed in 45 patients (31%) in the TPI group. In these 45 patients, the median duration of grade 2 urinary symptoms was 23 months (range, 12 to 70 months). On the other hand, acute grade 2 urinary symptoms resolved within 4 to 6 weeks after completion of 3D-CRT, and the 5-year actuarial likelihood of late grade 2 urinary toxicity for the 3D-CRT group was only 8%. The 5-year actuarial likelihood of developing a urethral stricture (grade 3 urinary toxicity) for the 3D-CRT and TPI groups was 2% and 12%, respectively (P<.0002). Of 45 patients who developed grade 2 or higher urinary toxicity after TPI, the likelihood of resolution or significant improvement of these symptoms at 36 months from onset was 59%. The 5-year likelihood of grade 2 late rectal toxicity for the 3D-CRT and TPI patients was similar (6% and 11%, respectively; P = .97). No patient in either group developed grade 3 or higher late rectal toxicity. The 5-year likelihood of posttreatment erectile dysfunction among patients who were initially potent before therapy was 43% for the 3D-CRT group and 53% for the TPI group (P = .52). CONCLUSION: Both 3D-CRT and TPI are associated with an excellent PSA outcome for patients with early-stage prostate cancer. Urinary toxicities are more prevalent for the TPI group and subsequently resolve or improve in most patients. In addition to evaluating long-term follow-up, future comparisons will require detailed quality-of-life assessments to further determine the impact of these toxicities on the overall well-being and quality of life of the individual patient.  (+info)

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. (2/1081)

BACKGROUND AND METHODS: We compared the effect of radiotherapy to a pelvic and para-aortic field with that of pelvic radiation and concurrent chemotherapy with fluorouracil and cisplatin in women with advanced cervical cancer. Between 1990 and 1997, 403 women with advanced cervical cancer confined to the pelvis (stages IIB through IVA or stage IB or IIa with a tumor diameter of at least 5 cm or involvement of pelvic lymph nodes) were randomly assigned to receive either 45 Gy of radiation to the pelvis and para-aortic lymph nodes or 45 Gy of radiation to the pelvis alone plus two cycles of fluorouracil and cisplatin (days 1 through 5 and days 22 through 26 of radiation). Patients were then to receive one or two applications of low-dose-rate intracavitary radiation, with a third cycle of chemotherapy planned for the second intracavitary procedure in the combined-therapy group. RESULTS: Of the 403 eligible patients, 193 in each group could be evaluated. The median duration of follow-up was 43 months. Estimated cumulative rates of survival at five years were 73 percent among patients treated with radiotherapy and chemotherapy and 58 percent among patients treated with radiotherapy alone (P=0.004). Cumulative rates of disease-free survival at five years were 67 percent among patients in the combined-therapy group and 40 percent among patients in the radiotherapy group (P<0.001). The rates of both distant metastases (P<0.001) and locoregional recurrences (P<0.001) were significantly higher among patients treated with radiotherapy alone. The seriousness of side effects was similar in the two groups, with a higher rate of reversible hematologic effects in the combined-therapy group. CONCLUSIONS: The addition of chemotherapy with fluorouracil and cisplatin to treatment with external-beam and intracavitary radiation significantly improved survival among women with locally advanced cervical cancer.  (+info)

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. (3/1081)

BACKGROUND AND METHODS: On behalf of the Gynecologic Oncology Group, we performed a randomized trial of radiotherapy in combination with three concurrent chemotherapy regimens -- cisplatin alone; cisplatin, fluorouracil, and hydroxyurea; and hydroxyurea alone -- in patients with locally advanced cervical cancer. Women with primary untreated invasive squamous-cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix of stage IIB, III, or IVA, without involvement of the para-aortic lymph nodes, were enrolled. The patients had to have a leukocyte count of at least 3000 per cubic millimeter, a platelet count of at least 100,000 per cubic millimeter, a serum creatinine level no higher than 2 mg per deciliter (177 micromol per liter), and adequate hepatic function. All patients received external-beam radiotherapy according to a strict protocol. Patients were randomly assigned to receive one of three chemotherapy regimens: 40 mg of cisplatin per square meter of body-surface area per week for six weeks (group 1); 50 mg of cisplatin per square meter on days 1 and 29, followed by 4 g of fluorouracil per square meter given as a 96-hour infusion on days 1 and 29, and 2 g of oral hydroxyurea per square meter twice weekly for six weeks (group 2); or 3 g of oral hydroxyurea per square meter twice weekly for six weeks (group 3). RESULTS: The analysis included 526 women. The median duration of follow-up was 35 months. Both groups that received cisplatin had a higher rate of progression-free survival than the group that received hydroxyurea alone (P<0.001 for both comparisons). The relative risks of progression of disease or death were 0.57 (95 percent confidence interval, 0.42 to 0.78) in group 1 and 0.55 (95 percent confidence interval, 0.40 to 0.75) in group 2, as compared with group 3. The overall survival rate was significantly higher in groups 1 and 2 than in group 3, with relative risks of death of 0.61 (95 percent confidence interval, 0.44 to 0.85) and 0.58 (95 percent confidence interval, 0.41 to 0.81), respectively. CONCLUSIONS: Regimens of radiotherapy and chemotherapy that contain cisplatin improve the rates of survival and progression-free survival among women with locally advanced cervical cancer.  (+info)

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. (4/1081)

BACKGROUND: Bulky stage IB cervical cancers have a poorer prognosis than smaller stage I cervical cancers. For the Gynecologic Oncology Group, we conducted a trial to determine whether weekly infusions of cisplatin during radiotherapy improve progression-free and overall survival among patients with bulky stage IB cervical cancer. METHODS: Women with bulky stage IB cervical cancers (tumor, > or =4 cm in diameter) were randomly assigned to receive radiotherapy alone or in combination with cisplatin (40 mg per square meter of body-surface area once a week for up to six doses; maximal weekly dose, 70 mg), followed in all patients by adjuvant hysterectomy. Women with evidence of lymphadenopathy on computed tomographic scanning or lymphangiography were ineligible unless histologic analysis showed that there was no lymph-node involvement. The cumulative dose of external pelvic and intracavitary radiation was 75 Gy to point A (cervical parametrium) and 55 Gy to point B (pelvic wall). Cisplatin was given during external radiotherapy, and adjuvant hysterectomy was performed three to six weeks later. RESULTS: The relative risks of progression of disease and death among the 183 women assigned to receive radiotherapy and chemotherapy with cisplatin, as compared with the 186 women assigned to receive radiotherapy alone, were 0.51 (95 percent confidence interval, 0.34 to 0.75) and 0.54 (95 percent confidence interval, 0.34 to 0.86), respectively. The rates of both progression-free survival (P<0.001) and overall survival (P=0.008) were significantly higher in the combined-therapy group at four years. In the combined-therapy group there were higher frequencies of transient grade 3 (moderate) and grade 4 (severe) adverse hematologic effects (21 percent, vs. 2 percent in the radiotherapy group) and adverse gastrointestinal effects (14 percent vs. 5 percent). CONCLUSIONS: Adding weekly infusions of cisplatin to pelvic radiotherapy followed by hysterectomy significantly reduced the risk of disease recurrence and death in women with bulky stage IB cervical cancers.  (+info)

The Denolin Lecture 1998. Towards measurement of coronary blood flow in patients and its alteration by interventions. (5/1081)

AIM: Several methods of measuring coronary blood flow in intact conscious man are reviewed, on the basis of personal contributions or the experiences of our teams. METHODS AND RESULTS: It is important to distinguish between global, regional and transmural blood flow measurements. The advantages and limitations of the following methods are discussed: diffusible inert and radioactive tracers, dye dilution, roentgendensitometry, magnetic resonance imaging and contrast echocardiography. In interventional cardiology it is most important to be able to measure flow through single coronary vessels. Information on coronary artery Doppler velocity during vasodilation and at rest is less useful than the concept of fractional flow reserve. This is based on pressure measurements under maximal vasodilation to ascertain the presence of borderline flow-limiting lesions. This information is necessary in order to decide whether to proceed with angioplasty or not. CONCLUSIONS: The historical design of percutaneous coronary angioplasty and beta-irradiation of coronary restenosis, established under the author's guidance, are put into perspective. The author pays tribute to many excellent colleagues who worked with him at the Zurich and Geneva University Hospitals.  (+info)

Bromodeoxyuridine alternating with radiation for advanced uterine cervix cancer: a phase I and drug incorporation study. (6/1081)

PURPOSE: Preclinical studies show a significant increase in the ratio of the radiosensitizer bromodeoxyuridine (BUdR) in tumors versus the intestinal mucosa during the drug elimination period, compared with the ratio during drug infusion. We constructed a phase I study in patients with locally advanced cervix cancer, using alternating cycles of BUdR and radiation therapy (RT). PATIENTS AND METHODS: Eighteen patients with stage IIB to IVA cervix cancer participated. A treatment cycle consisted of a 4-day BUdR infusion followed by a week of pelvic RT, 15 Gy twice daily in 1.5-Gy fractions. After three cycles, additional BUdR was infused, followed by brachytherapy. The fraction of thymidine replaced by BUdR and the fraction of cells incorporating BUdR were determined in rectal mucosa and tumor biopsies at the end of the first BUdR infusion (day 5), at the middle of the first RT week (day 10), and at the time of brachytherapy. RESULTS: Dose-limiting toxicity was observed in one of 16 patients receiving 1,000 mg/m2/d x 4 days and in both patients receiving 1,333 mg/m2/d x 4 days each cycle. After a median follow-up of 39 months, 12 patients (66%) were free of pelvic disease and nine (50%) were alive and disease free. The ratio of tumor to rectum BUdR incorporation averaged 1.5 to 1.8 and did not differ significantly between day 5 and day 10. A trend toward reduced ratio was observed at brachytherapy. Drug-containing cells in rectal biopsies migrated from the crypts to the mucosal surface. CONCLUSION: In this schedule, 1,000 mg/m2/d is the maximum-tolerated dose of BUdR. BUdR incorporation levels in tumors were consistent with clinically significant radiosensitization. The migration of BUdR-containing rectal mucosa cells from the crypts to the surface at the time of RT suggests that this regimen may offer a relative sparing of the mucosa from radiosensitization.  (+info)

Late coronary occlusion after intracoronary brachytherapy. (7/1081)

BACKGROUND: Intracoronary brachytherapy appears to be a promising technology to prevent restenosis. Presently, limited data are available regarding the late safety of this therapeutic modality. The aim of the study was to determine the incidence of late (>1 month) thrombosis after PTCA and radiotherapy. METHODS AND RESULTS: From April 1997 to March 1999, we successfully treated 108 patients with PTCA followed by intracoronary beta-radiation. Ninety-one patients have completed at least 2 months of clinical follow-up. Of these patients, 6.6% (6 patients) presented with sudden thrombotic events confirmed by angiography 2 to 15 months after intervention (2 balloon angioplasty and 4 stent). Some factors (overlapping stents, unhealed dissection) may have triggered the thrombosis process, but the timing of the event is extremely unusual. Therefore, the effect of radiation on delaying the healing process and maintaining a thrombogenic coronary surface is proposed as the most plausible mechanism to explain such late events. CONCLUSIONS: Late and sudden thrombosis after PTCA followed by intracoronary radiotherapy is a new phenomenon in interventional cardiology.  (+info)

Proliferative potential of malignant glioma cells before and after interstitial brachytherapy. (8/1081)

The viability of tumor cells in radionecrotic tissue after interstitial brachytherapy (BRTX) was evaluated using immunohistochemical markers of proliferative potential in primary and recurrent tumors. Tumor specimens from 30 patients with malignant gliomas (14 anaplastic astrocytomas, 16 glioblastomas) taken before and after BRTX were examined using MIB-1 monoclonal antibody. Histological examination of specimens obtained by craniotomy or stereotactic biopsy after BRTX revealed tumor recurrence in 18 patients and radionecrosis in 12 patients including two with pure radionecrosis and 10 with a mixture of both tumor and radionecrosis. The MIB-1 index of the tumors with radionecrosis was 7.6 +/- 5.5%, and that of the primary tumors was 17.0 +/- 11.2%, showing a significant difference (p < 0.05). There was no significant difference between the MIB-1 index of the primary tumors with local recurrence after BRTX and the primary tumors which underwent radionecrosis. Although morphologically viable tumor cells were found in the radionecrotic tissue, BRTX causes a reduction in the proliferative potential of these tumor cells.  (+info)

Brachytherapy is a type of cancer treatment that involves placing radioactive material directly into or near the tumor site. The term "brachy" comes from the Greek word for "short," which refers to the short distance that the radiation travels. This allows for a high dose of radiation to be delivered directly to the tumor while minimizing exposure to healthy surrounding tissue.

There are two main types of brachytherapy:

1. Intracavitary brachytherapy: The radioactive material is placed inside a body cavity, such as the uterus or windpipe.
2. Interstitial brachytherapy: The radioactive material is placed directly into the tumor or surrounding tissue using needles, seeds, or catheters.

Brachytherapy can be used alone or in combination with other cancer treatments such as surgery, external beam radiation therapy, and chemotherapy. It may be recommended for a variety of cancers, including prostate, cervical, vaginal, vulvar, head and neck, and skin cancers. The specific type of brachytherapy used will depend on the size, location, and stage of the tumor.

The advantages of brachytherapy include its ability to deliver a high dose of radiation directly to the tumor while minimizing exposure to healthy tissue, which can result in fewer side effects compared to other forms of radiation therapy. Additionally, brachytherapy is often a shorter treatment course than external beam radiation therapy, with some treatments lasting only a few minutes or hours.

However, there are also potential risks and side effects associated with brachytherapy, including damage to nearby organs and tissues, bleeding, infection, and pain. Patients should discuss the benefits and risks of brachytherapy with their healthcare provider to determine if it is an appropriate treatment option for them.

Iridium radioisotopes are unstable isotopes or variants of the element iridium that emit radiation as they decay into more stable forms. These isotopes can be used in various medical applications, such as brachytherapy, a type of cancer treatment where a small amount of radioactive material is placed inside the body near the tumor site to deliver targeted radiation therapy.

Iridium-192 is one commonly used iridium radioisotope for this purpose. It has a half-life of 74.2 days and emits gamma rays, making it useful for treating various types of cancer, including breast, gynecological, prostate, and head and neck cancers.

It's important to note that handling and using radioisotopes requires specialized training and equipment due to the potential radiation hazards associated with them.

Radiotherapy dosage refers to the total amount of radiation energy that is absorbed by tissues or organs, typically measured in units of Gray (Gy), during a course of radiotherapy treatment. It is the product of the dose rate (the amount of radiation delivered per unit time) and the duration of treatment. The prescribed dosage for cancer treatments can range from a few Gray to more than 70 Gy, depending on the type and location of the tumor, the patient's overall health, and other factors. The goal of radiotherapy is to deliver a sufficient dosage to destroy the cancer cells while minimizing damage to surrounding healthy tissues.

Computer-assisted radiotherapy planning (CARP) is the use of computer systems and software to assist in the process of creating a treatment plan for radiotherapy. The goal of radiotherapy is to deliver a precise and effective dose of radiation to a tumor while minimizing exposure to healthy tissue. CARP involves using imaging data, such as CT or MRI scans, to create a 3D model of the patient's anatomy. This model is then used to simulate the delivery of radiation from different angles and determine the optimal treatment plan. The use of computers in this process allows for more accurate and efficient planning, as well as the ability to easily adjust the plan as needed.

Radiation injuries refer to the damages that occur to living tissues as a result of exposure to ionizing radiation. These injuries can be acute, occurring soon after exposure to high levels of radiation, or chronic, developing over a longer period after exposure to lower levels of radiation. The severity and type of injury depend on the dose and duration of exposure, as well as the specific tissues affected.

Acute radiation syndrome (ARS), also known as radiation sickness, is the most severe form of acute radiation injury. It can cause symptoms such as nausea, vomiting, diarrhea, fatigue, fever, and skin burns. In more severe cases, it can lead to neurological damage, hemorrhage, infection, and death.

Chronic radiation injuries, on the other hand, may not appear until months or even years after exposure. They can cause a range of symptoms, including fatigue, weakness, skin changes, cataracts, reduced fertility, and an increased risk of cancer.

Radiation injuries can be treated with supportive care, such as fluids and electrolytes replacement, antibiotics, wound care, and blood transfusions. In some cases, surgery may be necessary to remove damaged tissue or control bleeding. Prevention is the best approach to radiation injuries, which includes limiting exposure through proper protective measures and monitoring radiation levels in the environment.

Ruthenium radioisotopes refer to unstable isotopes of the element ruthenium, which decays or disintegrates spontaneously emitting radiation. Ruthenium is a rare transition metal with the atomic number 44 and has several radioisotopes, including ruthenium-97, ruthenium-103, ruthenium-105, and ruthenium-106. These radioisotopes have medical applications in diagnostic imaging, radiation therapy, and brachytherapy (a type of internal radiation therapy).

For instance, ruthenium-106 is used as a radiation source in ophthalmic treatments for conditions such as neovascular age-related macular degeneration and diabetic retinopathy. Ruthenium-103 is also used in brachytherapy seeds for the treatment of prostate cancer.

It's important to note that handling and using radioisotopes require specialized training, equipment, and safety measures due to their radiation hazards.

Dose fractionation is a medical term that refers to the practice of dividing the total dose of radiation therapy or chemotherapy into smaller doses, which are given over a longer period. This approach allows for the delivery of a higher total dose of treatment while minimizing damage to healthy tissues and reducing side effects.

In radiation therapy, fractionation is used to target cancer cells while sparing surrounding normal tissues. By delivering smaller doses of radiation over several treatments, healthy tissue has time to recover between treatments, reducing the risk of complications. The number and size of fractions can vary depending on the type and location of the tumor, as well as other factors such as the patient's overall health.

Similarly, in chemotherapy, dose fractionation is used to maximize the effectiveness of the treatment while minimizing toxicity. By administering smaller doses of chemotherapy over time, the body has a chance to recover between treatments, reducing side effects and allowing for higher total doses to be given. The schedule and duration of chemotherapy fractionation may vary depending on the type of drug used, the type and stage of cancer, and other factors.

Overall, dose fractionation is an important technique in both radiation therapy and chemotherapy that allows for more effective treatment while minimizing harm to healthy tissues.

Prostatic neoplasms refer to abnormal growths in the prostate gland, which can be benign or malignant. The term "neoplasm" simply means new or abnormal tissue growth. When it comes to the prostate, neoplasms are often referred to as tumors.

Benign prostatic neoplasms, such as prostate adenomas, are non-cancerous overgrowths of prostate tissue. They usually grow slowly and do not spread to other parts of the body. While they can cause uncomfortable symptoms like difficulty urinating, they are generally not life-threatening.

Malignant prostatic neoplasms, on the other hand, are cancerous growths. The most common type of prostate cancer is adenocarcinoma, which arises from the glandular cells in the prostate. Prostate cancer often grows slowly and may not cause any symptoms for many years. However, some types of prostate cancer can be aggressive and spread quickly to other parts of the body, such as the bones or lymph nodes.

It's important to note that while prostate neoplasms can be concerning, early detection and treatment can significantly improve outcomes for many men. Regular check-ups with a healthcare provider are key to monitoring prostate health and catching any potential issues early on.

Radiometry is the measurement of electromagnetic radiation, including visible light. It quantifies the amount and characteristics of radiant energy in terms of power or intensity, wavelength, direction, and polarization. In medical physics, radiometry is often used to measure therapeutic and diagnostic radiation beams used in various imaging techniques and cancer treatments such as X-rays, gamma rays, and ultraviolet or infrared light. Radiometric measurements are essential for ensuring the safe and effective use of these medical technologies.

Image-guided radiotherapy (IGRT) is a type of radiation therapy that uses medical imaging techniques to improve the precision and accuracy of radiation delivery. It allows for real-time or periodic imaging during the course of radiation treatment, which can be used to confirm the position of the targeted tumor and make any necessary adjustments to the patient's position or the radiation beam. This helps ensure that the radiation is focused on the intended target, while minimizing exposure to surrounding healthy tissue. IGRT may be used to treat a variety of cancer types and can be delivered using various radiation therapy techniques such as 3D-conformal radiotherapy, intensity-modulated radiotherapy (IMRT), or stereotactic body radiotherapy (SBRT).

Vaginal neoplasms refer to abnormal growths or tumors in the vagina. These growths can be benign (non-cancerous) or malignant (cancerous). The two main types of vaginal neoplasms are:

1. Vaginal intraepithelial neoplasia (VAIN): This is a condition where the cells on the inner lining of the vagina become abnormal but have not invaded deeper tissues. VAIN can be low-grade or high-grade, depending on the severity of the cell changes.
2. Vaginal cancer: This is a malignant tumor that arises from the cells in the vagina. The two main types of vaginal cancer are squamous cell carcinoma and adenocarcinoma. Squamous cell carcinoma is the most common type, accounting for about 85% of all cases.

Risk factors for vaginal neoplasms include human papillomavirus (HPV) infection, smoking, older age, history of cervical cancer or precancerous changes, and exposure to diethylstilbestrol (DES) in utero. Treatment options depend on the type, stage, and location of the neoplasm but may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Uterine cervical neoplasms, also known as cervical cancer or cervical dysplasia, refer to abnormal growths or lesions on the lining of the cervix that have the potential to become cancerous. These growths are usually caused by human papillomavirus (HPV) infection and can be detected through routine Pap smears.

Cervical neoplasms are classified into different grades based on their level of severity, ranging from mild dysplasia (CIN I) to severe dysplasia or carcinoma in situ (CIN III). In some cases, cervical neoplasms may progress to invasive cancer if left untreated.

Risk factors for developing cervical neoplasms include early sexual activity, multiple sexual partners, smoking, and a weakened immune system. Regular Pap smears and HPV testing are recommended for early detection and prevention of cervical cancer.

Beta particles, also known as beta rays, are a type of ionizing radiation that consist of high-energy electrons or positrons emitted from the nucleus of certain radioactive isotopes during their decay process. When a neutron in the nucleus decays into a proton, it results in an excess energy state and one electron is ejected from the atom at high speed. This ejected electron is referred to as a beta particle.

Beta particles can have both positive and negative charges, depending on the type of decay process. Negative beta particles (β−) are equivalent to electrons, while positive beta particles (β+) are equivalent to positrons. They possess kinetic energy that varies in range, with higher energies associated with greater penetrating power.

Beta particles can cause ionization and excitation of atoms and molecules they encounter, leading to chemical reactions and potential damage to living tissues. Therefore, appropriate safety measures must be taken when handling materials that emit beta radiation.

Iodine radioisotopes are radioactive isotopes of the element iodine, which decays and emits radiation in the form of gamma rays. Some commonly used iodine radioisotopes include I-123, I-125, I-131. These radioisotopes have various medical applications such as in diagnostic imaging, therapy for thyroid disorders, and cancer treatment.

For example, I-131 is commonly used to treat hyperthyroidism and differentiated thyroid cancer due to its ability to destroy thyroid tissue. On the other hand, I-123 is often used in nuclear medicine scans of the thyroid gland because it emits gamma rays that can be detected by a gamma camera, allowing for detailed images of the gland's structure and function.

It is important to note that handling and administering radioisotopes require specialized training and safety precautions due to their radiation-emitting properties.

Computer-assisted radiotherapy, also known as computerized radiation therapy planning or treatment planning system, is a medical procedure that utilizes advanced computer software to design and implement a radiotherapy treatment plan for patients with cancer. This process involves using imaging technologies such as CT, MRI, or PET scans to create a 3D model of the tumor and surrounding healthy tissues. The software then calculates the optimal radiation dose and beam orientation to deliver the maximum radiation to the tumor while minimizing exposure to healthy tissue.

The computer-assisted radiotherapy system allows for more precise and accurate treatment planning, which can lead to improved outcomes and reduced side effects for patients undergoing radiation therapy. It also enables clinicians to simulate and compare different treatment plans, allowing them to choose the most effective and safe option for each individual patient. Additionally, the use of computer-assisted radiotherapy can increase efficiency and streamline the treatment planning process, reducing wait times for patients and improving workflow in radiotherapy departments.

A dose-response relationship in radiation refers to the correlation between the amount of radiation exposure (dose) and the biological response or adverse health effects observed in exposed individuals. As the level of radiation dose increases, the severity and frequency of the adverse health effects also tend to increase. This relationship is crucial in understanding the risks associated with various levels of radiation exposure and helps inform radiation protection standards and guidelines.

The effects of ionizing radiation can be categorized into two types: deterministic and stochastic. Deterministic effects have a threshold dose below which no effect is observed, and above this threshold, the severity of the effect increases with higher doses. Examples include radiation-induced cataracts or radiation dermatitis. Stochastic effects, on the other hand, do not have a clear threshold and are based on probability; as the dose increases, so does the likelihood of the adverse health effect occurring, such as an increased risk of cancer.

Understanding the dose-response relationship in radiation exposure is essential for setting limits on occupational and public exposure to ionizing radiation, optimizing radiation protection practices, and developing effective medical countermeasures in case of radiation emergencies.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

I'm sorry for any confusion, but "Ytterbium" is not a medical term. It is a chemical element with the symbol "Yb" and atomic number 70. Ytterbium is a rare earth metal that is silvery white, soft, malleable, and has many uses in scientific research, particularly in the field of laser technology.

If you have any medical questions or terms you would like me to define, please let me know!

Combined modality therapy (CMT) is a medical treatment approach that utilizes more than one method or type of therapy simultaneously or in close succession, with the goal of enhancing the overall effectiveness of the treatment. In the context of cancer care, CMT often refers to the combination of two or more primary treatment modalities, such as surgery, radiation therapy, and systemic therapies (chemotherapy, immunotherapy, targeted therapy, etc.).

The rationale behind using combined modality therapy is that each treatment method can target cancer cells in different ways, potentially increasing the likelihood of eliminating all cancer cells and reducing the risk of recurrence. The specific combination and sequence of treatments will depend on various factors, including the type and stage of cancer, patient's overall health, and individual preferences.

For example, a common CMT approach for locally advanced rectal cancer may involve preoperative (neoadjuvant) chemoradiation therapy, followed by surgery to remove the tumor, and then postoperative (adjuvant) chemotherapy. This combined approach allows for the reduction of the tumor size before surgery, increases the likelihood of complete tumor removal, and targets any remaining microscopic cancer cells with systemic chemotherapy.

It is essential to consult with a multidisciplinary team of healthcare professionals to determine the most appropriate CMT plan for each individual patient, considering both the potential benefits and risks associated with each treatment method.

Radiotherapy, also known as radiation therapy, is a medical treatment that uses ionizing radiation to kill cancer cells, shrink tumors, and prevent the growth and spread of cancer. The radiation can be delivered externally using machines or internally via radioactive substances placed in or near the tumor. Radiotherapy works by damaging the DNA of cancer cells, which prevents them from dividing and growing. Normal cells are also affected by radiation, but they have a greater ability to repair themselves compared to cancer cells. The goal of radiotherapy is to destroy as many cancer cells as possible while minimizing damage to healthy tissue.

Tongue neoplasms refer to abnormal growths or tumors that develop in the tongue tissue. These growths can be benign (non-cancerous) or malignant (cancerous).

Benign tongue neoplasms may include entities such as papillomas, fibromas, or granular cell tumors. They are typically slow growing and less likely to spread to other parts of the body.

Malignant tongue neoplasms, on the other hand, are cancers that can invade surrounding tissues and spread to other parts of the body. The most common type of malignant tongue neoplasm is squamous cell carcinoma, which arises from the thin, flat cells (squamous cells) that line the surface of the tongue.

Tongue neoplasms can cause various symptoms such as a lump or thickening on the tongue, pain or burning sensation in the mouth, difficulty swallowing or speaking, and unexplained bleeding from the mouth. Early detection and treatment are crucial for improving outcomes and preventing complications.

Choroid neoplasms are abnormal growths that develop in the choroid, a layer of blood vessels that lies between the retina and the sclera (the white of the eye). These growths can be benign or malignant (cancerous). Benign choroid neoplasms include choroidal hemangiomas and choroidal osteomas. Malignant choroid neoplasms are typically choroidal melanomas, which are the most common primary eye tumors in adults. Other types of malignant choroid neoplasms include metastatic tumors that have spread to the eye from other parts of the body. Symptoms of choroid neoplasms can vary depending on the size and location of the growth, but may include blurred vision, floaters, or a dark spot in the visual field. Treatment options depend on the type, size, and location of the tumor, as well as the patient's overall health and personal preferences.

Fat necrosis is a medical condition that refers to the death (necrosis) of fat cells, typically due to injury or trauma. This can occur when there is an interruption of blood flow to the area, leading to the death of fat cells and the release of their contents. The affected area may become firm, nodular, or lumpy, and can sometimes be mistaken for a tumor.

Fat necrosis can also occur as a result of pancreatic enzymes leaking into surrounding tissues due to conditions such as pancreatitis. These enzymes can break down fat cells, leading to the formation of calcium soaps that can be seen on imaging studies.

While fat necrosis is not typically a serious condition, it can cause discomfort or pain in the affected area. In some cases, surgical intervention may be necessary to remove the affected tissue.

Radiation dosage, in the context of medical physics, refers to the amount of radiation energy that is absorbed by a material or tissue, usually measured in units of Gray (Gy), where 1 Gy equals an absorption of 1 Joule of radiation energy per kilogram of matter. In the clinical setting, radiation dosage is used to plan and assess the amount of radiation delivered to a patient during treatments such as radiotherapy. It's important to note that the biological impact of radiation also depends on other factors, including the type and energy level of the radiation, as well as the sensitivity of the irradiated tissues or organs.

The rectum is the lower end of the digestive tract, located between the sigmoid colon and the anus. It serves as a storage area for feces before they are eliminated from the body. The rectum is about 12 cm long in adults and is surrounded by layers of muscle that help control defecation. The mucous membrane lining the rectum allows for the detection of stool, which triggers the reflex to have a bowel movement.

Rectal diseases refer to conditions that affect the structure or function of the rectum, which is the lower end of the large intestine, just above the anus. The rectum serves as a storage area for stool before it is eliminated from the body. Some common rectal diseases include:

1. Hemorrhoids: Swollen veins in the rectum or anus that can cause pain, itching, bleeding, and discomfort.
2. Rectal cancer: Abnormal growth of cells in the rectum that can invade and destroy nearby tissue and spread to other parts of the body.
3. Anal fissures: Small tears in the lining of the anus that can cause pain, bleeding, and itching.
4. Rectal prolapse: A condition where the rectum slips outside the anus, causing discomfort, fecal incontinence, and other symptoms.
5. Inflammatory bowel disease (IBD): A group of chronic inflammatory conditions that affect the digestive tract, including the rectum, such as Crohn's disease and ulcerative colitis.
6. Rectal abscess: A collection of pus in the rectum caused by an infection, which can cause pain, swelling, and fever.
7. Fistula-in-ano: An abnormal connection between the rectum and the skin around the anus, which can cause drainage of pus or stool.
8. Rectal foreign bodies: Objects that are accidentally or intentionally inserted into the rectum and can cause injury, infection, or obstruction.

These are just a few examples of rectal diseases, and there are many other conditions that can affect the rectum. If you experience any symptoms related to the rectum, it is important to seek medical attention from a healthcare professional for proper diagnosis and treatment.

Interventional Magnetic Resonance Imaging (MRI) is a medical imaging technique that combines the diagnostic capabilities of MRI with minimally invasive image-guided procedures. It uses a strong magnetic field, radio waves, and computer software to produce detailed images of the body's internal structures and soft tissues.

In interventional MRI, the technology is used in real-time to guide the placement of needles, catheters, or other medical instruments for diagnostic or therapeutic purposes. This can include biopsies, tumor ablations, or targeted drug deliveries. The primary advantage of interventional MRI over traditional interventional radiology techniques is its ability to provide high-resolution imaging without the use of radiation, making it a safer option for certain patients. However, it requires specialized equipment and trained personnel to perform these procedures.

Urinary retention is a medical condition in which the bladder cannot empty completely or at all, resulting in the accumulation of urine in the bladder. This can lead to discomfort, pain, and difficulty in passing urine. Urinary retention can be acute (sudden onset) or chronic (long-term). Acute urinary retention is a medical emergency that requires immediate attention, while chronic urinary retention may be managed with medications or surgery. The causes of urinary retention include nerve damage, bladder muscle weakness, prostate gland enlargement, and side effects of certain medications.

Conformal radiotherapy is a type of external beam radiation therapy that uses advanced technology to conform the radiation beam to the shape of the tumor, allowing for more precise and targeted treatment while minimizing exposure to healthy surrounding tissue. This can help reduce the risk of side effects and improve the therapeutic ratio. Conformal radiotherapy techniques include 3D conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT). These techniques use sophisticated imaging and treatment planning systems to create a personalized treatment plan for each patient, based on the size, shape, and location of their tumor.

"Organs at Risk" (OARs) is a term commonly used in the field of radiation oncology. It refers to normal, vital organs and tissues that are located near a tumor or within the path of a radiation beam during cancer treatment. These structures are at risk of being damaged or injured by the radiation therapy, which can lead to side effects and complications. Examples of OARs include the heart, lungs, spinal cord, brain, kidneys, liver, and intestines. The goal of radiation therapy planning is to maximize the dose delivered to the tumor while minimizing the dose to the surrounding OARs.

Local neoplasm recurrence is the return or regrowth of a tumor in the same location where it was originally removed or treated. This means that cancer cells have survived the initial treatment and started to grow again in the same area. It's essential to monitor and detect any local recurrence as early as possible, as it can affect the prognosis and may require additional treatment.

Histiocytoma is a general term used to describe a group of disorders characterized by an abnormal accumulation or proliferation of histiocytes, which are a type of immune cell. These cells normally play a role in fighting infection and helping to heal wounds. However, when they multiply excessively, they can form tumors known as histiocytomas.

There are several types of histiocytomas, including:

1. Cutaneous histiocytoma: This is the most common type of histiocytoma, which typically appears as a small, raised, hairless, and pink or red bump on the skin. It usually affects dogs, but can also occur in cats and rarely in humans. These tumors are benign and often regress spontaneously within a few months.
2. Systemic histiocytoses: These are less common types of histiocytomas that involve multiple organs and tissues throughout the body. They can be further classified into several subtypes, such as Langerhans cell histiocytosis (LCH), Erdheim-Chester disease (ECD), and malignant histiocytosis. These conditions can range from benign to malignant and may require aggressive treatment, including chemotherapy or radiation therapy.

It is important to note that while histiocytomas are generally benign, they can sometimes mimic other more serious conditions. Therefore, it is essential to have any suspicious growths evaluated by a veterinarian or healthcare professional for proper diagnosis and management.

Uveal neoplasms refer to tumors that originate in the uveal tract, which is the middle layer of the eye. The uveal tract includes the iris (the colored part of the eye), ciliary body (structures behind the iris that help focus light), and choroid (a layer of blood vessels that provides nutrients to the retina). Uveal neoplasms can be benign or malignant, with malignant uveal melanoma being the most common primary intraocular cancer in adults. These tumors can cause various symptoms, such as visual disturbances, eye pain, or floaters, and may require treatment to preserve vision and prevent metastasis.

Urination disorders, also known as lower urinary tract symptoms (LUTS), refer to a range of clinical conditions that affect the bladder and urethra, resulting in abnormalities in the storage, transportation, and evacuation of urine. These disorders can be categorized into voiding symptoms, such as hesitancy, straining, slow stream, intermittency, and terminal dribble; and storage symptoms, including frequency, urgency, nocturia, and urge incontinence.

The causes of urination disorders are diverse, encompassing congenital abnormalities, neurological conditions, infections, inflammation, medications, and age-related changes. Common underlying pathologies include bladder overactivity, detrusor muscle instability, underactive bladder, and obstruction of the urethra.

Urination disorders can significantly impact an individual's quality of life, causing physical discomfort, sleep disturbances, emotional distress, and social isolation. Accurate diagnosis and appropriate management require a comprehensive assessment of the patient's medical history, physical examination, urinalysis, and urodynamic studies. Treatment options may include behavioral modifications, pelvic floor exercises, bladder training, medications, neuromodulation, and surgical interventions.

Strontium radioisotopes are radioactive isotopes of the element strontium. Strontium is an alkaline earth metal that is found in nature and has several isotopes, some of which are stable and some of which are radioactive. The radioactive isotopes of strontium, also known as strontium radionuclides, decay and emit radiation in the form of beta particles.

Strontium-89 (^89Sr) and strontium-90 (^90Sr) are two common radioisotopes of strontium that are used in medical applications. Strontium-89 is a pure beta emitter with a half-life of 50.5 days, which makes it useful for the treatment of bone pain associated with metastatic cancer. When administered, strontium-89 is taken up by bones and irradiates the bone tissue, reducing pain and improving quality of life in some patients.

Strontium-90, on the other hand, has a longer half-life of 28.8 years and emits more powerful beta particles than strontium-89. It is used as a component in radioactive waste and in some nuclear weapons, but it is not used in medical applications due to its long half-life and high radiation dose.

It's important to note that exposure to strontium radioisotopes can be harmful to human health, especially if ingested or inhaled. Therefore, handling and disposal of strontium radioisotopes require special precautions and regulations.

Radioisotopes, also known as radioactive isotopes or radionuclides, are variants of chemical elements that have unstable nuclei and emit radiation in the form of alpha particles, beta particles, gamma rays, or conversion electrons. These isotopes are formed when an element's nucleus undergoes natural or artificial radioactive decay.

Radioisotopes can be produced through various processes, including nuclear fission, nuclear fusion, and particle bombardment in a cyclotron or other types of particle accelerators. They have a wide range of applications in medicine, industry, agriculture, research, and energy production. In the medical field, radioisotopes are used for diagnostic imaging, radiation therapy, and in the labeling of molecules for research purposes.

It is important to note that handling and using radioisotopes requires proper training, safety measures, and regulatory compliance due to their ionizing radiation properties, which can pose potential health risks if not handled correctly.

Prosthesis implantation is a surgical procedure where an artificial device or component, known as a prosthesis, is placed inside the body to replace a missing or damaged body part. The prosthesis can be made from various materials such as metal, plastic, or ceramic and is designed to perform the same function as the original body part.

The implantation procedure involves making an incision in the skin to create a pocket where the prosthesis will be placed. The prosthesis is then carefully positioned and secured in place using screws, cement, or other fixation methods. In some cases, tissue from the patient's own body may be used to help anchor the prosthesis.

Once the prosthesis is in place, the incision is closed with sutures or staples, and the area is bandaged. The patient will typically need to undergo rehabilitation and physical therapy to learn how to use the new prosthesis and regain mobility and strength.

Prosthesis implantation is commonly performed for a variety of reasons, including joint replacement due to arthritis or injury, dental implants to replace missing teeth, and breast reconstruction after mastectomy. The specific procedure and recovery time will depend on the type and location of the prosthesis being implanted.

Radioisotope teletherapy is a type of cancer treatment that uses high-energy radiation from a radioisotope to destroy cancer cells. In this procedure, the radioisotope is placed outside the body and aimed at the tumor site, rather than being inserted into the body like in brachytherapy. The radiation travels through space and penetrates the tissue to reach the tumor, where it damages the DNA of cancer cells and inhibits their ability to divide and grow. This type of radiotherapy is often used for larger or more difficult-to-reach tumors, as well as for palliative care in advanced stages of cancer. Examples of radioisotopes commonly used in teletherapy include cobalt-60 and cesium-137.

High-energy radiotherapy, also known as external beam radiation therapy (EBRT), is a type of cancer treatment that uses high-energy radiation beams to destroy cancer cells and shrink tumors. The radiation beams are produced by a machine called a linear accelerator (LINAC) and are directed at the tumor site from outside the body. High-energy radiotherapy can be used to treat many different types of cancer, either alone or in combination with other treatments such as surgery or chemotherapy.

The high-energy radiation beams used in this type of radiotherapy are able to penetrate deep into the body and target large areas, making it an effective treatment for cancers that have spread or are too large to be removed surgically. The dose and duration of treatment will depend on the type and stage of cancer being treated, as well as the patient's overall health.

High-energy radiotherapy works by damaging the DNA of cancer cells, which prevents them from dividing and growing. This ultimately leads to the death of the cancer cells. While radiation therapy can also damage normal cells, they are generally better able to repair themselves compared to cancer cells. Therefore, the goal of high-energy radiotherapy is to deliver a high enough dose to destroy the cancer cells while minimizing harm to surrounding healthy tissue.

It's important to note that high-energy radiotherapy requires careful planning and delivery to ensure that the radiation beams are focused on the tumor site and avoid healthy tissues as much as possible. This is typically done using imaging techniques such as CT, MRI, or PET scans to create a treatment plan that maps out the exact location and shape of the tumor. The patient will then undergo a series of treatments, usually scheduled daily over several weeks.

Glossectomy is a surgical procedure that involves the partial or total removal of the tongue. This type of surgery may be performed for various reasons, such as treating certain types of cancer (like oral or tongue cancer) that have not responded to other forms of treatment, or removing a portion of the tongue that's severely damaged or injured due to trauma.

The extent of the glossectomy depends on the size and location of the tumor or lesion. A partial glossectomy refers to the removal of a part of the tongue, while a total glossectomy involves the complete excision of the tongue. In some cases, reconstructive surgery may be performed to help restore speech and swallowing functions after the procedure.

It is essential to note that a glossectomy can significantly impact a patient's quality of life, as the tongue plays crucial roles in speaking, swallowing, and taste sensation. Therefore, multidisciplinary care involving speech therapists, dietitians, and other healthcare professionals is often necessary to help patients adapt to their new conditions and optimize their recovery process.

Radiation oncology is a branch of medicine that uses ionizing radiation in the treatment and management of cancer. The goal of radiation therapy, which is the primary treatment modality in radiation oncology, is to destroy cancer cells or inhibit their growth while minimizing damage to normal tissues. This is achieved through the use of high-energy radiation beams, such as X-rays, gamma rays, and charged particles, that are directed at the tumor site with precision. Radiation oncologists work in interdisciplinary teams with other healthcare professionals, including medical physicists, dosimetrists, and radiation therapists, to plan and deliver effective radiation treatments for cancer patients.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

X-ray computed tomography (CT or CAT scan) is a medical imaging method that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional (tomographic) images (virtual "slices") of the body. These cross-sectional images can then be used to display detailed internal views of organs, bones, and soft tissues in the body.

The term "computed tomography" is used instead of "CT scan" or "CAT scan" because the machines take a series of X-ray measurements from different angles around the body and then use a computer to process these data to create detailed images of internal structures within the body.

CT scanning is a noninvasive, painless medical test that helps physicians diagnose and treat medical conditions. CT imaging provides detailed information about many types of tissue including lung, bone, soft tissue and blood vessels. CT examinations can be performed on every part of the body for a variety of reasons including diagnosis, surgical planning, and monitoring of therapeutic responses.

In computed tomography (CT), an X-ray source and detector rotate around the patient, measuring the X-ray attenuation at many different angles. A computer uses this data to construct a cross-sectional image by the process of reconstruction. This technique is called "tomography". The term "computed" refers to the use of a computer to reconstruct the images.

CT has become an important tool in medical imaging and diagnosis, allowing radiologists and other physicians to view detailed internal images of the body. It can help identify many different medical conditions including cancer, heart disease, lung nodules, liver tumors, and internal injuries from trauma. CT is also commonly used for guiding biopsies and other minimally invasive procedures.

In summary, X-ray computed tomography (CT or CAT scan) is a medical imaging technique that uses computer-processed combinations of many X-ray images taken from different angles to produce cross-sectional images of the body. It provides detailed internal views of organs, bones, and soft tissues in the body, allowing physicians to diagnose and treat medical conditions.

Radiation protection, also known as radiation safety, is a field of study and practice that aims to protect people and the environment from harmful effects of ionizing radiation. It involves various measures and techniques used to minimize or eliminate exposure to ionizing radiation, such as:

1. Time: Reducing the amount of time spent near a radiation source.
2. Distance: Increasing the distance between oneself and a radiation source.
3. Shielding: Using materials that can absorb or block radiation to reduce exposure.
4. Containment: Preventing the release of radiation into the environment.
5. Training and education: Providing information and training to individuals who work with radiation sources.
6. Dosimetry and monitoring: Measuring and monitoring radiation doses received by individuals and populations.
7. Emergency planning and response: Developing plans and procedures for responding to radiation emergencies or accidents.

Radiation protection is an important consideration in various fields, including medicine, nuclear energy, research, and manufacturing, where ionizing radiation sources are used or produced.

Prostate-Specific Antigen (PSA) is a glycoprotein enzyme produced by the epithelial cells of the prostate gland. It is primarily involved in liquefying semen after ejaculation, allowing sperm mobility.

In clinical medicine, PSA is used as a tumor marker, mainly for monitoring the treatment and recurrence of prostate cancer. Elevated levels of PSA can indicate inflammation, infection, benign prostatic hyperplasia (BPH), or prostate cancer. However, it's important to note that an elevated PSA level does not necessarily confirm cancer; further diagnostic tests like digital rectal examination, transrectal ultrasound, and prostate biopsy are often required for definitive diagnosis.

Doctors may also use PSA isoforms or derivatives, such as free PSA, total PSA, and PSA density, to help improve the specificity of cancer detection and differentiate between malignant and benign conditions.

Adjuvant radiotherapy is a type of cancer treatment that uses radiation therapy as an adjunct to a primary surgical procedure. The goal of adjuvant radiotherapy is to eliminate any remaining microscopic cancer cells that may be present in the surrounding tissues after surgery, thereby reducing the risk of local recurrence and improving the chances of cure.

Radiotherapy involves the use of high-energy radiation to destroy cancer cells and shrink tumors. In adjuvant radiotherapy, the radiation is usually delivered to the tumor bed and regional lymph nodes in order to target any potential sites of residual disease. The timing and dosing of adjuvant radiotherapy may vary depending on the type and stage of cancer being treated, as well as other factors such as patient age and overall health status.

Adjuvant radiotherapy is commonly used in the treatment of various types of cancer, including breast, colorectal, lung, head and neck, and gynecologic cancers. Its use has been shown to improve survival rates and reduce the risk of recurrence in many cases, making it an important component of comprehensive cancer care.

Androgen antagonists are a class of drugs that block the action of androgens, which are hormones that contribute to male sexual development and characteristics. They work by binding to androgen receptors in cells, preventing the natural androgens from attaching and exerting their effects. This can be useful in treating conditions that are caused or worsened by androgens, such as prostate cancer, hirsutism (excessive hair growth in women), and acne. Examples of androgen antagonists include flutamide, bicalutamide, and spironolactone.

Coronary restenosis is the re-narrowing or re-occlusion of a coronary artery after a previous successful procedure to open or widen the artery, such as angioplasty or stenting. This narrowing is usually caused by the excessive growth of scar tissue or smooth muscle cells in the artery lining, which can occur spontaneously or as a response to the initial procedure. Restenosis can lead to recurrent symptoms of coronary artery disease, such as chest pain or shortness of breath, and may require additional medical intervention.

Genital neoplasms in females refer to abnormal growths or tumors that occur in the female reproductive organs. These can be benign (non-cancerous) or malignant (cancerous). The most common types of female genital neoplasms are:

1. Cervical cancer: This is a malignancy that arises from the cells lining the cervix, usually caused by human papillomavirus (HPV) infection.
2. Uterine cancer: Also known as endometrial cancer, this type of female genital neoplasm originates in the lining of the uterus (endometrium).
3. Ovarian cancer: This is a malignancy that develops from the cells in the ovaries, which can be difficult to detect at an early stage due to its location and lack of symptoms.
4. Vulvar cancer: A rare type of female genital neoplasm that affects the external female genital area (vulva).
5. Vaginal cancer: This is a malignancy that occurs in the vagina, often caused by HPV infection.
6. Gestational trophoblastic neoplasia: A rare group of tumors that develop from placental tissue and can occur during or after pregnancy.

Regular screening and early detection are crucial for successful treatment and management of female genital neoplasms.

The sigmoid colon is a part of the large intestine that forms an "S"-shaped curve before it joins the rectum. It gets its name from its unique shape, which resembles the Greek letter sigma (σ). The main function of the sigmoid colon is to store stool temporarily and assist in the absorption of water and electrolytes from digestive waste before it is eliminated from the body.

Neoplasm staging is a systematic process used in medicine to describe the extent of spread of a cancer, including the size and location of the original (primary) tumor and whether it has metastasized (spread) to other parts of the body. The most widely accepted system for this purpose is the TNM classification system developed by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC).

In this system, T stands for tumor, and it describes the size and extent of the primary tumor. N stands for nodes, and it indicates whether the cancer has spread to nearby lymph nodes. M stands for metastasis, and it shows whether the cancer has spread to distant parts of the body.

Each letter is followed by a number that provides more details about the extent of the disease. For example, a T1N0M0 cancer means that the primary tumor is small and has not spread to nearby lymph nodes or distant sites. The higher the numbers, the more advanced the cancer.

Staging helps doctors determine the most appropriate treatment for each patient and estimate the patient's prognosis. It is an essential tool for communication among members of the healthcare team and for comparing outcomes of treatments in clinical trials.

I'm sorry for any confusion, but "Rhenium" is not a medical term. It is a chemical element with the symbol "Re" and atomic number 75. Rhenium is a heavy, silvery-white, metallic element that is highly resistant to corrosion and is used in high-temperature alloys and electronics.

It does not have any direct medical relevance or application as a drug, treatment, or diagnostic tool in human medicine. However, like many other elements, rhenium compounds are being studied for their potential medicinal uses, such as in cancer therapy. But it's important to note that these are still in the research phase and have not yet been approved for use in humans.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

In the field of medical imaging, "phantoms" refer to physical objects that are specially designed and used for calibration, quality control, and evaluation of imaging systems. These phantoms contain materials with known properties, such as attenuation coefficients or spatial resolution, which allow for standardized measurement and comparison of imaging parameters across different machines and settings.

Imaging phantoms can take various forms depending on the modality of imaging. For example, in computed tomography (CT), a common type of phantom is the "water-equivalent phantom," which contains materials with similar X-ray attenuation properties as water. This allows for consistent measurement of CT dose and image quality. In magnetic resonance imaging (MRI), phantoms may contain materials with specific relaxation times or magnetic susceptibilities, enabling assessment of signal-to-noise ratio, spatial resolution, and other imaging parameters.

By using these standardized objects, healthcare professionals can ensure the accuracy, consistency, and reliability of medical images, ultimately contributing to improved patient care and safety.

A segmental mastectomy, also known as a partial mastectomy, is a surgical procedure that involves the removal of a portion of the breast tissue. This type of mastectomy is typically used to treat breast cancer that is limited to a specific area of the breast. During the procedure, the surgeon removes the cancerous tumor along with some surrounding healthy tissue, as well as the lining of the chest wall below the tumor and the lymph nodes in the underarm area.

In a segmental mastectomy, the goal is to remove the cancer while preserving as much of the breast tissue as possible. This approach can help to achieve a more cosmetic outcome compared to a total or simple mastectomy, which involves removing the entire breast. However, the extent of the surgery will depend on the size and location of the tumor, as well as other factors such as the patient's overall health and personal preferences.

It is important to note that while a segmental mastectomy can be an effective treatment option for breast cancer, it may not be appropriate for all patients or tumors. The decision to undergo this procedure should be made in consultation with a healthcare provider, taking into account the individual patient's medical history, diagnosis, and treatment goals.

... to treat breast cancer is usually performed with HDR temporary brachytherapy. Post surgery, breast brachytherapy ... "American Brachytherapy Society cervical cancer brachytherapy task group" (PDF). American Brachytherapy Society. Retrieved 25 ... February 2007). "American Brachytherapy Society breast brachytherapy task group" (PDF). American Brachytherapy Society. ... "Patterns of Care for Brachytherapy in Europe: Facilities and resources in brachytherapy in the European area". Brachytherapy. 7 ...
Brachytherapy is now in widespread use across the world. In the UK, prostate brachytherapy is provided at a majority of cancer ... There are two types of brachytherapy - high dose-rate (HDR) and low dose-rate (LDR). LDR brachytherapy is the one most commonly ... LDR prostate brachytherapy on its own has been shown to be highly effective for the treatment of early prostate cancer. The ... LDR brachytherapy has fewer side-effects with less risk of incontinence or impotence than other treatment options. It is a ...
... -170 is gaining popularity as an X-ray source for cancer treatment via brachytherapy (sealed source radiation therapy). ... Ayoub, Amal; Shani, Gad (2009). "Development of New Radioactive Seeds Tm-170 for Brachytherapy". In Dössel, Olaf; Schlegel, ... "Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources ... ". Brachytherapy. 10 (6): 461-465. doi:10.1016/j.brachy.2011.01.012. PMID 21397569. ...
It can then be imaged by CT or MRI so that targeted brachytherapy can be tailored to the lesion as the malignancy evolves. Smit ... Brachytherapy. 14 (6): 905-9. doi:10.1016/j.brachy.2015.07.005. PMID 26329165. v t e (Articles with short description, Short ... MRI-based target delineation for cervical cancer treatment within a rapid workflow environment for image-guided brachytherapy: ...
Cesaretti, JA; Sheu, R-D; Yeh-Chi, L; Stoch, RG; Jenkins, AL (2008). "A novel technique of intracavitary 125I Brachytherapy for ... vertebral body metastases". Brachytherapy. 7 (2): 164-5. doi:10.1016/j.brachy.2008.02.224. Singh, H; Meyer, SA; Hecht, A; ...
2017). "American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A ... 2015). "Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment- ... 2016). "Evaluation and Classification of Vaginal Stenosis After Brachytherapy". Texto & Contexto - Enfermagem. 25 (2). doi: ... or brachytherapy. Radiation-induced vaginal stenosis can be a side effect of treatment. It is one of the most prevalent side ...
Aronowitz, Jesse N.; Robison, Roger F. (2010). "Howard Kelly establishes gynecologic brachytherapy in the United States". ... Brachytherapy. 9 (2): 178-184. doi:10.1016/j.brachy.2009.10.001. PMID 20022564. Skloot, Rebecca (2 February 2010). The Immortal ...
"American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive ... However, most cervical cancers are asymptomatic (present no symptoms). Vaginal intracavity brachytherapy (VBT) is used to treat ... "Cervical, Endometrial, Vaginal and Vulvar Cancers - Gynecologic Brachytherapy". radonc.ucla.edu. Archived from the original on ... "Vaginal cuff brachytherapy in endometrial cancer - a technically easy treatment?". Cancer Management and Research. 9: 351-362. ...
"What is Brachytherapy?". American Brachytherapy Society. Retrieved 8 August 2020. "Surgery for Prostate Cancer". www.cancer.org ... Brachytherapy with implanted seeds (for prostate cancer) was first described in 1983. Systemic chemotherapy for prostate cancer ... called brachytherapy. Cancer that has spread to other parts of the body is usually treated also with hormone therapy, to ...
"Axxent Electronic Brachytherapy". Swedish Covenant Hospital. Retrieved 2011-03-21. "ICAD INC - FORM 10-Q ...", company U.S. ... Swedish Covenant Hospital in Chicago offered Xoft's Axxent Electronic Brachytherapy System treatment, beginning in 2008. The ... "iCAD to acquire electronic brachytherapy specialist Xoft" (press release), medicalphysicsweb.org, December 17, 2010. Jarzemsky ... the Axxent Electronic Brachytherapy System, was found to have left test subjects "riddled ... with hundreds of tiny particles ...
... or by brachytherapy, where a radioactive source is surgically placed next to the prostate. Radiotherapy is typically given in ... "Brachytherapy". Brawley, Mohan & Nein 2018, "Radiation Therapy". Dall'Era 2023, "Radical Prostatectomy". Scher & Eastham 2022 ...
Journal of Contemporary Brachytherapy. 6 (3): 297-299. doi:10.5114/jcb.2014.45133. PMC 4200180. PMID 25337133. Sredniawa, ...
... brachytherapy'. Among his early work were experiments in dark vision to determine why reading fluoroscopes was so challenging ...
The Hazy Dawn of Brachytherapy. Radiotherapy and Oncology (49) 1998 223-232 Harvie, David I. The Radium Century. Endeavor 1999 ...
Contact X-ray brachytherapy (also called "CXB", "electronic brachytherapy" or the "Papillon Technique") is a type of radiation ... Brachytherapy is delivered by placing radiation source(s) inside or next to the area requiring treatment. Brachytherapy is ... 2007). "Radiobiological concepts for brachytherapy". In Devlin P (ed.). Brachytherapy. Applications and Techniques. ... A course of brachytherapy can often be completed in less time than other radiation therapy techniques. This can help reduce the ...
Notes "About Isoray - Personalized Brachytherapy Products". "Cesium Blu by Isoray - Treating Prostate Cancer with Brachytherapy ... The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray's corporate headquarters ... Isoray) is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding ... Isoray is a registered manufacturer with the FDA and holds multiple 510(k) clearances for brachytherapy devices. ...
Harmony Search Optimization for HDR Prostate Brachytherapy. 2008. ISBN 9780549534365. Archived from the original on 2016-03-06 ...
Brachytherapy treatment options v t e (Articles with short description, Short description matches Wikidata, Orgasm, All stub ... Merrick GS, Wallner K, Butler WM, Lief JH, Sutlief S (October 2001). "Short-term sexual function after prostate brachytherapy ...
In 2016, the institute installed a "Flexitron Cobalt-60 High Dose Rate" brachytherapy system from Elekta. The system is part of ... Vision Reporter (9 April 2016). "Mulago's new brachytherapy system improves cancer treatment". New Vision. Kampala. Retrieved 9 ...
Nag S, Beyer D, Friedland J, Grimm P, Nath R (July 1999). "American Brachytherapy Society (ABS) recommendations for ... Others use a "triple modality" combination of external beam radiation therapy, brachytherapy, and hormonal therapy. In advanced ... "Radiation Therapy for Prostate Cancer: Prostate Brachytherapy". Archived from the original on 2010-03-04. Retrieved 2010-03-17 ... Radiation therapy used in prostate cancer treatment include external beam radiation therapy and brachytherapy (specifically ...
The department is providing Brachytherapy facility also. Other Radiation oncologists at CCI are Dr. Johny Joseph (previously ...
"A 10-year experience of pediatric brachytherapy". International Journal of Radiation Oncology, Biology, Physics. 32 (2): 451- ...
In brachytherapy planning involves selecting the appropriate catheter positions and source dwell times (in HDR brachytherapy) ... Brachytherapy planning Image-guided radiation therapy Thariat, Juliette; Hannoun-Levi, Jean-Michel; Sun Myint, Arthur; Vuong, ... or seed positions (in LDR brachytherapy). The more formal optimization process is typically referred to as forward planning and ... Optimization of Catheter Position and Dwell Time in Prostate HDR Brachytherapy using HIPO and Linear Programming. World ...
The Axxent Electronic Brachytherapy has not been recalled. Hoag Heart & Vascular Institute offers surgical techniques including ... In the media: The hospital's Axxent FlexiShield Mini study-treatment adjunct to the Axxent Electronic Brachytherapy breast ...
These include brachytherapy, biopsy, neuroscience research and tumor removal. One type of tumor removal that would greatly ...
Small lesions can be treated with iodine-125 plaque brachytherapy. Distant metastases and mortality are rare. Mortality may ... "Management of medulloepithelioma of the ciliary body with brachytherapy". American Journal of Ophthalmology. 133 (6): 841-843. ...
The same properties of the isotope make it useful for brachytherapy, and for certain nuclear medicine scanning procedures, in ... The 126I tolerable content (which is set by the unwanted isotope interfering with dose calculations in brachytherapy) lies at ... Iodine-125 is used therapeutically in brachytherapy treatments of tumors. For radiotherapy ablation of tissues that absorb ... Pd-103 for permanent prostate brachytherapy accessed June 22, 2010. Boutrot, Freddy; Zipfel, Cyril (2017-08-04). "Function, ...
Brachytherapy and EBRT can also be used, singly or in combination, when there is a contraindication for hysterectomy. Both ... It can be delivered through vaginal brachytherapy (VBT), which is becoming the preferred route due to its reduced toxicity, or ... external beam radiotherapy (EBRT). Brachytherapy involves placing a radiation source in the organ affected; in the case of ...
These included three Linear Accelerators, brachytherapy machine and treatment planning systems. The treatments that are ... brachytherapy machines, Magnetic Resonance Imaging (MRI Scanners) and CT scans were due to be installed in the centre. The ...
Collé and collaborators developed methods to analyse and standardize brachytherapy sources, pellets of radioactive material ... Collé, R. (1999). "Chemical digestion and radionuclidic assay of TiNi-encapsulated 32P intravascular brachytherapy sources". ... "National radioactivity standards for beta-emitting radionuclides used in intravascular brachytherapy". International Journal of ...
Brachytherapy to treat breast cancer is usually performed with HDR temporary brachytherapy. Post surgery, breast brachytherapy ... "American Brachytherapy Society cervical cancer brachytherapy task group" (PDF). American Brachytherapy Society. Retrieved 25 ... February 2007). "American Brachytherapy Society breast brachytherapy task group" (PDF). American Brachytherapy Society. ... "Patterns of Care for Brachytherapy in Europe: Facilities and resources in brachytherapy in the European area". Brachytherapy. 7 ...
You had a procedure called brachytherapy to treat prostate cancer. Your treatment lasted 30 minutes or more, depending on the ... You had a procedure called brachytherapy to treat prostate cancer. Your treatment lasted 30 minutes or more, depending on the ...
Brachytherapy for breast cancer involves placing radioactive material directly in the area where breast cancer has been removed ... Brachytherapy for breast cancer involves placing radioactive material directly in the area where breast cancer has been removed ... brachytherapy; APBI - brachytherapy; Accelerated partial breast irradiation - brachytherapy; Partial breast radiation therapy ... Electronic balloon brachytherapy; EBB; Intracavitary brachytherapy; IBB; Interstitial brachytherapy; IMB ...
American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy. 2012; doi:10.1016 ... American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. ... See a list of publications about permanent prostate brachytherapy by Mayo Clinic doctors on PubMed, a service of the National ... The evolution of brachytherapy for prostate cancer. Nature Reviews Urology. 2017; doi:10.1038/nrurol.2017.76. ...
Brachytherapy is a treatment for cancer where radioactive sources are placed in or directly next to the tumor. ... Brachytherapy is a treatment for cancer where radioactive sources are placed in or directly next to the tumor. The radioactive ... The advantage of brachytherapy is that the radiation dose is delivered directly to the tumor while very little radiation is ... Common sites implanted using brachytherapy at University Hospital are prostate, head and neck, cervix, endometrium, lung, brain ...
ABS (American Brachytherapy Society) 2021 Annual Meeting , Varian. Skip to main content ... ABS (American Brachytherapy Society) 2021 Annual Meeting. Jun 25, 21 - Jun 27, 21 National Harbor, MD ... ": "ABS (American Brachytherapy Society) 2021 Annual Meeting", "eventStartDates": "Jun 25, 21", "eventEndDate": "Jun 27, 21", " ...
... Brachytherapy. 2014 Nov- ... We present our experience using image-based brachytherapy (BT). Methods and materials: Patients with medically inoperable ... Copyright © 2014 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved. ...
Learn how brachytherapy, an internal form of radiation treatment for cancer, allows doctors to deliver higher doses of ... 5. Does brachytherapy require a hospital stay?. It depends on the cancer you have and the kind of brachytherapy that you ... Does brachytherapy require a hospital stay? * Whats the difference between low dose rate brachytherapy and high dose rate ... How does brachytherapy compare with other forms of radiation treatments? * How often is brachytherapy treatment given, and how ...
"Thus, if a brachytherapy boost is to be used for intermediate- or high-risk disease, our data suggest that the addition of ADT ... RT Plus ADT Tops Brachytherapy Boost for Prostate Cancer. - Meta-analysis may help decision making, but direct comparisons ... The available data do not inform the appropriate duration of ADT when brachytherapy is employed or adequately refine the ... "However, this analysis importantly highlights the lack of data exploring the potential of brachytherapy as an effective and ...
Figure 1: Brachytherapy sources implemented in the Geant4 Advanced Example Brachytherapy. Sizes not to scale.. The Flexisource ... This example allows to calculate the energy deposition/dose in a water phantom produced by a brachytherapy source. The user can ... is a source commonly used for high dose rate brachytherapy treatments. The geometry of the Flexisource was adapted from D. ... "A generic high-dose rate 192Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism ...
The global brachytherapy treatment planning systems market size was valued at USD 757.5 million in 2022 and is projected to ... Brachytherapy Treatment Planning Systems Market Report, 2030 GVR Report cover Brachytherapy Treatment Planning Systems Market ... What is the brachytherapy treatment planning systems market growth? b. The global brachytherapy treatment planning systems ... How big is the brachytherapy treatment planning systems market? b. The global brachytherapy treatment planning systems market ...
I am scheduled to start HDR Brachytherapy on Sept. ... I had brachytherapy too, I had brachytherapy too, although I ... Difference in Brachytherapy Hi Mamado:. I hope all went well for you on your treatment day. I think the difference between the ... Brachytherapy The doctor did say I would be sedated and would need someone to drive me home after each treatment. I was told 3- ... Brachytherapy. The doctor did say I would be sedated and would need someone to drive me home after each treatment. I was told 3 ...
Discover our solutions for efficient and effective image-guided brachytherapy with a smart positioning board and afterloader. ... Brachytherapy brings radiation directly to the tumor and image-guided brachytherapy can increase further the treatment, the ... Afterloader needed for brachytherapy. Shielding of the CT room is required when it is used for brachytherapy. ... Make your image-guided brachytherapy workflow more efficient. *One drawback of the standard brachytherapy workflow: Patients ...
The global brachytherapy treatment planning systems market size was valued at USD 757.5 million in 2022 and is projected to ... Brachytherapy Treatment Planning Systems Market Report, 2030. Brachytherapy Treatment Planning Systems Market Size, Share & ... U.S. brachytherapy treatment planning systems market, by component, 2017 - 2030 (USD Million). Table 21. U.S. brachytherapy ... U.K. brachytherapy treatment planning systems market, by component, 2017 - 2030 (USD Million). Table 28. U.K. brachytherapy ...
... Brachytherapy. 2003;2(1):1-2. doi: 10.1016/S1538-4721(03)00011-4 ...
2023 Prostate Brachytherapy Workshop: Back to the Future in Seattle. A Hands-on Learning Experience.. Future Meetings. Past ... Brachytherapy Applications. #NextGenBrachy. Prostate Seeds. Scholarship & Fellowship Programs. Related Web Site Links. Sponsors ... American Brachytherapy Society Fact Sheet. Henschke Award Recipients. Corporate Members. Membership Application. ABS Volunteer ... Join the ABS today to join over 1,000 of your colleagues in the field of brachytherapy. Membership and is complementary to ...
Air-kerma strength determination of a miniature x-ray source for brachytherapy applications Davis, Stephen D. The University of ...
Prostate brachytherapy is a treatment for prostate tumors or prostate cancer. Localized radiotherapy that avoids important side ... High-rate whole - gland prostate brachytherapy Low-rate prostate brachytherapy, also known as permanent implantation or ... HIGH RATE BRACHYTHERAPY. What is the process of prostate brachytherapy? *First phase (implantation): Performed in a surgical ... Brachytherapy is a type of radiotherapy that allows high doses of irradiation to be delivered directly to the tumour. This ...
Brachytherapy or internal radiation therapy allows for a precise cancer treatment in only a few minutes. Learn what it is, ... Types of brachytherapy. High-dose rate (HDR) brachytherapy. This internal radiation therapy delivers a high-dose of radiation ... How is brachytherapy implanted?. The care team will typically insert brachytherapy into the patients body through a catheter ... What is brachytherapy?. Brachytherapy is cancer treatment that involves placing a radiation source inside the body near ...
Brachytherapy - One Mans Meat, A Personal Journey in Radiation Oncology. TH Khor 3 January 2022. ...
American Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate Cancer. Author: ... The American Brachytherapy Society (ABS) published the updated recommendations for transperineal permanent brachytherapy of ... American Brachytherapy Society (ABS) Recommendations for Transperineal Permanent Brachytherapy of Prostate Cancer ... Brachytherapy as monotherapy is indicated in patients with stage T1 to T2a, Gleason sum of 2-6, and PSA , 10ng/ml prostate ...
... per square millimeter as maintained by CMS falls under Brachytherapy Sources ... HCPCS Code C2645 for Brachytherapy planar source, Palladium-103, ... HCPCS Code for Brachytherapy planar source, Palladium-103, per ... HCPCS code C2645 for Brachytherapy planar source, Palladium-103, per square millimeter as maintained by CMS falls under ... Brachytherapy Sources.. Subscribe to Codify by AAPC and get the code details in a flash.. Request a Demo 14 Day Free Trial Buy ...
Imaging equipment used in brachytherapy has changed a lot over the last 15 years. Previously, hospitals relied on 2D X-rays to ... The challenges of brachytherapy. *Improving the workflow. There are many people involved in image-guided brachytherapy: ... What this means for the future of image-guided brachytherapy. Image-guided brachytherapy is becoming an essential part of ... "Many countries are using image-guided brachytherapy, but I think its important that we do all we can to increase its use ...
A considerable proportion of Medicare beneficiaries are treated with brachytherapy for breast cancer, with substantial regional ... The researchers found that 15.8% of 29,648 women received brachytherapy, with the percentage of women receiving brachytherapy ... Carolyn J. Presley, MD, from Yale University in New Haven, CT, and colleagues examined brachytherapy treatment patterns and ... Considerable Regional Variation for Brachytherapy A considerable proportion of Medicare beneficiaries are treated with ...
At the time of my brachytherapy, no one was able to tell me the long term effects of brachytherapy because they didnt know. As ... The brachytherapy itself only took less than 30 mintues from set up to finish. I know places do it differently though. ... I was offered brachytherapy a year ago as something that *might* eradicate the remaining cancer cells in my vaginal tissues, ... After the chemo, I did have brachytherapy. I had a small recurrence in 2010 of which I just had surgery. They removed a lymph ...
Safe and Curative Brachytherapy Reirradiation with Organ-Sparing Hyaluronate Gel Injection. Written By ... Chapter 3 Progress in Californium-252 Neutron Brachytherapy By C.-K. Chris Wang ...
Home , Services and Departments , Cancer , Brachytherapy , Brachytherapy frequently asked questions. Brachytherapy frequently ...
Explore a comprehensive list of world-class accredited hospitals for Brachytherapy treatment in Bangalore, India. Request for ... Hospitals For Brachytherapy in Bangalore. *Choose from 5 JCI certified clinics and hospitals ...
  • Treatment results have demonstrated that the cancer-cure rates of brachytherapy are either comparable to surgery and external beam radiotherapy (EBRT) or are improved when used in combination with these techniques. (wikipedia.org)
  • Brachytherapy contrasts with unsealed source radiotherapy, in which a therapeutic radionuclide (radioisotope) is injected into the body to chemically localize to the tissue requiring destruction. (wikipedia.org)
  • Ch. 1 A course of brachytherapy can be completed in less time than other radiotherapy techniques. (wikipedia.org)
  • Patients receiving brachytherapy generally have to make fewer visits for radiotherapy compared with EBRT, and overall radiotherapy treatment plans can be completed in less time. (wikipedia.org)
  • Although radical prostatectomy for localized disease is considered as a standard of care, external-beam radiotherapy and brachytherapy are equally effective. (medscape.com)
  • Brachytherapy , may also be referred to as internal radiotherapy , which is your first clue to what it is. (canceractive.com)
  • Brachytherapy is radiotherapy where radioactive material is placed inside your body, next to or around a tumour. (canceractive.com)
  • Brachytherapy was first approved by the FDA in America in 2002 and, despite the hype, is an alternative cancer therapy to traditional radiotherapy. (canceractive.com)
  • An electronic form of brachytherapy could propel radiotherapy beyond oncology clinics and into radiology departments and possibly even imaging centers. (diagnosticimaging.com)
  • Partial breast radiotherapy using brachytherapy or 3D conformal radiotherapy has not yet proved equal to this technology in terms of local control. (diagnosticimaging.com)
  • Techniques include interstitial brachytherapy using multiple catheters, balloon breast brachytherapy using a catheter-based technology, and 3D conformal radiotherapy using a linear accelerator. (diagnosticimaging.com)
  • HDR brachytherapy involves delivering radiotherapy from inside the body by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. (varian.com)
  • Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. (varian.com)
  • However, other factors such as increased geriatric population and rising awareness of minimally-invasive radiotherapy procedures have been a great contributor to the growth of the brachytherapy devices market. (pharmiweb.com)
  • Pellizzon ACA, Salvajoli J, Novaes P, Maia M, Fogaroli R, Gides D, Horriot R. The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition. (medsci.org)
  • Purpose: To evaluated prognostic factors and impact of the quality of planning of high dose rate brachytherapy (HDR-BT) for patients with local or locally advanced prostate cancer treated with external beam radiotherapy (EBRT) and HDR-BT. (medsci.org)
  • To report the use of high-dose-rate (HDR) interventional radiotherapy (brachytherapy, IRT) as a salvage treatment for macroscopic histologically confirmed local relapse of prostatic cancer after prostatectomy and subsequent external irradiation. (termedia.pl)
  • We sought to evaluate contemporary trends in brachytherapy, external beam radiotherapy (EBRT) and prostatectomy utilization in a publicly funded healthcare system. (uwo.ca)
  • In a separate multivariable model limited to those who received radiotherapy, if the first radiation oncologist seen performed brachytherapy, the OR of receiving brachytherapy monotherapy over EBRT was 5.66 (95% CI: 5.11-6.26, p (uwo.ca)
  • Brachytherapy (or "internal radiation therapy") is another form of radiotherapy and is an advanced treatment for cancer diseases that involves placing seeds or radioactive sources in or near the tumour, which deliver a high dose of radiation into the tumour volume while reducing radiation exposure to healthy tissue. (amethyst-radiotherapy.ro)
  • Thus, brachytherapy is radiotherapy delivered at a short distance: localised, precise and high-tech. (amethyst-radiotherapy.ro)
  • For prostate cancer, disease-free survival is higher in patients treated with high dose rate brachytherapy combined with external beam radiotherapy compared to those treated with external beam radiotherapy alone. (engerlab.com)
  • Our group develops Monte Carlo based radiation dose calculation engines and treatment planning systems for use in conventional and intensity modulated brachytherapy, as well external beam radiotherapy. (engerlab.com)
  • Radiotherapy (including brachytherapy) is the main treatment for advanced cervical cancer. (who.int)
  • With the generous support of donor countries such as France, Japan, Monaco, Sweden, and the United States, the private sector and international financial institutions, Rays of Hope supports countries in the establishment and expansion of radiotherapy services, including brachytherapy, with a particular focus on more than 20 IAEA Member States that completely lack facilities for radiation treatment, most of which are in Africa. (who.int)
  • Low-dose rate brachytherapy is the most common type of treatment. (medlineplus.gov)
  • High-dose rate brachytherapy lasts about 30 minutes. (medlineplus.gov)
  • This is also called low-dose rate brachytherapy. (hopkinsmedicine.org)
  • For example, large and irregular gynecological tumors, which extend into the parametrial and/or paravaginal tissues cannot be treated with curative intend by using intracavitary brachytherapy implants alone without overdosing nearby healthy organs causing side effects but must be supplemented with invasive interstitial high dose rate brachytherapy to enable conformal dose delivery to the tumor while reducing dose to healthy tissues. (engerlab.com)
  • Our group is developing the next generation of high dose rate brachytherapy technology, including prototype delivery systems for intensity modulated brachytherapy treatment of prostate, cervix, vaginal and rectal cancers. (engerlab.com)
  • High-dose-rate brachytherapy is usually performed as an outpatient procedure, and radioactive seeds are inserted into a patient's body for up to 20 minutes. (urologylosangeles.com)
  • Low-dose-rate brachytherapy involves the use of a continuous low dose of radiation that is released over several hours or days. (urologylosangeles.com)
  • A patient will likely stay in a private room during low-dose-rate brachytherapy, as there is a small risk that the radioactive material inside his or her body may harm others. (urologylosangeles.com)
  • 3. Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer. (nih.gov)
  • 6. Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer. (nih.gov)
  • Recommendations from the American Brachytherapy Society, American Society of Radiation Oncology, and European Society for Medical Oncology help to guide the application of vaginal cuff brachytherapy. (nih.gov)
  • This report is endorsed by the American Brachytherapy Society. (aapm.org)
  • Along with radical prostatectomy , cryotherapy , and EBRT (also referred to as intensity-modulated radiation therapy [ IMRT ]), interstitial brachytherapy is a potentially curative treatment for localized prostate cancer. (medscape.com)
  • A platelet-mimicking theranostic platform for cancer interstitial brachytherapy. (bvsalud.org)
  • Between 20th July 1998 and 7th February 2006, 1500 patients underwent I-125 prostate brachytherapy without supplemental external beam radiation therapy. (urotoday.com)
  • Is prostate brachytherapy a dying art? (uwo.ca)
  • Background and purpose: Declining prostate brachytherapy utilization has been reported in several studies, despite strong evidence for efficacy and safety compared to alternatives. (uwo.ca)
  • Single-nucleotide polymorphisms studied for associations with urinary toxicity from (125)I prostate brachytherapy implants. (cdc.gov)
  • One analysis predicts that the brachytherapy market may reach over US$2.4 billion in 2030, growing by 8% annually, mainly driven by the microspheres market as well as electronic brachytherapy, which is gaining significant interest worldwide as a user-friendly technology. (wikipedia.org)
  • Study results suggest that electronic brachytherapy is an effective treatment for patients with non- melanoma skin cancer, with few recurrences or side effects and excellent cosmetic results," said Ajay Bhatnagar, MD, MBA, medical director of 21st Century Oncology of Arizona. (icadmed.com)
  • At the meeting, iCAD will also showcase its new comprehensive solution for clinical practices interested in implementing a skin electronic brachytherapy program. (icadmed.com)
  • The continued adoption of the Xoft System emphasizes that it is increasingly being used nationwide, in large and small communities, at large and small hospitals and underscores the growing demand for IORT and other electronic brachytherapy treatments. (salesandmarketingnetwork.com)
  • Florida Hospital Celebration Health is also participating in the company s 10 year post-market IORT study of the Xoft Axxent Electronic Brachytherapy System for early stage breast cancer. (salesandmarketingnetwork.com)
  • Xoft Axxent Electronic Brachytherapy System is an isotope-free radiation treatment cleared by the FDA for use anywhere in the body, including for the treatment of early stage breast cancer, endometrial cancer and skin cancer. (salesandmarketingnetwork.com)
  • These features of brachytherapy mean that most patients are able to tolerate the brachytherapy procedure very well. (wikipedia.org)
  • Brachytherapy is a procedure to implant radioactive seeds (pellets) into the prostate gland to kill prostate cancer cells. (medlineplus.gov)
  • This method allows for high specificity within the framework of a modern brachytherapy procedure, integrating the tumor topography, anatomy of the patient, and internal movements of target and critical volumes. (nih.gov)
  • In contrast, brachytherapy to treat breast cancer, for example, requires the placement of applicators delivering radiation inside the breast after mastectomy, and this procedure involves surgery. (amethyst-radiotherapy.ro)
  • These transfers are time and resource consuming and pose the risk of applicator displacement - which may result in a suboptimal brachytherapy procedure. (siemens-healthineers.com)
  • Brachytherapy is a minimally invasive procedure that may offer a quicker recovery period, less time in a hospital, and a limited risk of postoperative infection in comparison to other cancer treatments. (urologylosangeles.com)
  • Lorenzo's brachytherapy procedure took 45 minutes, and he was able to go home immediately. (cdc.gov)
  • Rather than irradiating larger areas of the breast, as in whole breast irradiation, brachytherapy temporarily implants radiation sources in catheters within the surgical site. (canceractive.com)
  • In temporary brachytherapy, catheters or needles are inserted into the patient's body, sometimes in different directions. (globehealer.com)
  • Brachytherapy is one of the most effective and precise radiation delivery modalities, where high activity radiation sources are placed directly into or near localized tumours using needles, plastic catheters or other specialized applicators giving a high radiation dose to the tumour while the dose to sensitive healthy tissues surrounding the tumour is lower. (engerlab.com)
  • These systems will enable anisotropic intensity modulation of brachytherapy dose distributions by incorporating rotating metallic shields inside brachytherapy catheters and applicators. (engerlab.com)
  • Global Brachytherapy catheters market is anticipated to reach a value of over USD xx billion by 2028 and register a CAGR of xx% for the forecast period 2021-2028. (hackpad.tw)
  • FutureWise Research has released a research report that analyses Brachytherapy catheters Market trends in order to forecast market growth. (hackpad.tw)
  • This Brachytherapy catheters research report includes in-depth information on the market's general overview, market segmentation, present and projected prices, growth analysis, competitive environment, and other vital insights throughout the course of the forecast year. (hackpad.tw)
  • The Brachytherapy catheters report examines market segmentation forecasts by type, by application, by end user, and region. (hackpad.tw)
  • HDR brachytherapy may be the most conformal type of irradiation in the treatment of carcinoma of the prostate regardless of tumor size, anatomical distortion, and organ mobility. (medscape.com)
  • Brachytherapy (the term is derived from the Greek word brachys, which means brief or short) refers to cancer treatment with ionizing radiation delivered via radioactive material placed a short distance from, or within, the tumor. (medscape.com)
  • This technique has been successfully extended to other tumor locations, such as genital tract rhabdomyosarcoma in children and postoperative endocavitary brachytherapy in patients with endometrial cancer. (nih.gov)
  • Brachytherapy brings radiation directly to the tumor and image-guided brachytherapy can increase further the treatment, the accuracy and reduce side-effects and toxicities. (siemens-healthineers.com)
  • Standard brachytherapy procedures allow radiation oncologists to get radiation directly to the tumor, minimizing dose to the surrounding healthy tissue. (siemens-healthineers.com)
  • For effective brachytherapy procedures, you need to see the tumor and the applicator clearly for accurate therapy planning and treatment. (siemens-healthineers.com)
  • The critical limitation with brachytherapy is the rotationally symmetric dose distribution provided by brachytherapy sources, delivering high dose to the tumor but often with poor tumor conformity due to the non-symmetrical shape of the tumors resulting in dose spillage to surrounding healthy tissues. (engerlab.com)
  • Magnetic resonance imaging (MRI) scans provide a doctor with 3D images that highlight tumor volume, as well as images that show how tumor volume and shape have changed between brachytherapy treatment sessions. (urologylosangeles.com)
  • An MRI allows a doctor to account for organs that may be at risk during brachytherapy and tumor regression or movement, too. (urologylosangeles.com)
  • He chose to have brachytherapy, a kind of internal radiation therapy where seeds, ribbons, or capsules that contain a radiation source are placed in your body, in or near the tumor. (cdc.gov)
  • The importance of the quality of cervical cancer brachytherapy applicators has been reported, suggesting a direct influence of competent technical implant performance on outcome. (nih.gov)
  • At Amethyst, intracavitary brachytherapy, HDR type, is performed in short sessions of 2-4 minutes depending on the type of treatment, i.e. curative or post-operative/neo-adjuvant. (amethyst-radiotherapy.ro)
  • As the radiation sources can be precisely positioned at the tumour treatment site, brachytherapy enables a high dose of radiation to be applied to a small area. (wikipedia.org)
  • We report on the technique and preliminary results of high-dose-rate (HDR) brachytherapy using a temporary iridium-192 implant technique. (medscape.com)
  • Either high-dose or low-dose brachytherapy may be used. (hopkinsmedicine.org)
  • High-dose-rate (HDR) brachytherapy allows a person to be treated for several minutes at a time with a powerful radioactive source that's put in the applicator. (cancer.org)
  • It is often referred to as High Dose-Rate (HDR) Brachytherapy , especially in the USA. (canceractive.com)
  • Brachytherapy may employ low- or high-dose techniques. (diagnosticimaging.com)
  • PALO ALTO, Calif., Jan. 24, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesseâ„¢ real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer. (varian.com)
  • The task group (TG) on magnetic resonance imaging (MRI) implementation in high-dose-rate (HDR) brachytherapy (BT) Considerations from simulation to treatment, TG 303, was constituted by the American Association of Physicists in Medicine's (AAPM's) Science Council under the direction of the Therapy Physics Committee, the Brachytherapy Subcommittee, and the Working Group on Brachytherapy Clinical Applications. (aapm.org)
  • The Flexitron treatment device, is a remote-controlled high dose rate (HDR) brachytherapy machine equipped with an encapsulated radioactive source containing the radioisotope Iridium 192. (amethyst-radiotherapy.ro)
  • The use of vaginal cuff brachytherapy in the adjuvant management of endometrial cancer has increased over time. (nih.gov)
  • This article reviews the use of vaginal cuff brachytherapy in the post-operative management of endometrial cancer. (nih.gov)
  • Also presented are early results of the Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE) trial of a two-fraction vaginal cuff brachytherapy regimen.Adjuvant vaginal cuff brachytherapy for early-stage endometrial cancer results in excellent disease control with minimal toxicity. (nih.gov)
  • Vaginal dilation after brachytherapy (and external beam radiation) is significant for the long-term function of the vagina and future pelvic exams. (americanbrachytherapy.org)
  • Customization of a vaginal brachytherapy applicator allows for the maintenance of morphologic optimization throughout the treatment course, which better takes into account a fourth dimension: internal organ motion during the course of brachytherapy. (nih.gov)
  • Key players such as Elekta AB and Accuray are investing in the research & developments of brachytherapy devices - image-guided brachytherapy (IBT), etc., which is one of the latest technologies introduced in the market. (pharmiweb.com)
  • 1 The GEC-ESTRO handbook of brachytherapy 2 and the ABS 3 guidelines highlight the importance of 3D image-guided brachytherapy in improving treatment outcome and in reducing toxicity. (siemens-healthineers.com)
  • In image-guided brachytherapy, the first step is to place the applicator or needles. (siemens-healthineers.com)
  • Discover our CT and MR imaging solutions for 3D image-guided brachytherapy. (siemens-healthineers.com)
  • In this work, a proof-of-concept is presented for reconstruction of the individual channels of a shielded tandem applicator dedicated to intensity modulated brachytherapy. (arxiv.org)
  • The Novel Brachytherapy Technology group is developing Monte Carlo-based treatment planning systems for conventional and intensity-modulated brachytherapy, intravascular brachytherapy, and 90 Y-based hepatic radioembolization as well as intensity-modulated brachytherapy delivery systems and novel radiation sources. (engerlab.com)
  • Intensity modulated brachytherapy will increase the probability of response and cure while avoiding toxicity, which will increase the quality of life of patients suffering from cancer. (engerlab.com)
  • Ch. 1 A feature of brachytherapy is that the irradiation affects only a very localized area around the radiation sources. (wikipedia.org)
  • The combination of HDR brachytherapy and external irradiation has been well tolerated by all 200 patients in our series, with less than 3% grade 3 late complications and with 95% PSA relapse-free survival with a median follow-up of 24 months. (medscape.com)
  • The team found that the use of brachytherapy was associated with a 16.9% higher rate of wound and skin complications in the year after treatment compared to whole breast irradiation. (canceractive.com)
  • A key feature of brachytherapy is that the radiation affects only a very localized area around the radiation source. (nih.gov)
  • Brachytherapy is commonly used as an effective treatment for cervical, prostate, breast, esophageal and skin cancer and can also be used to treat tumours in many other body sites. (wikipedia.org)
  • Brachytherapy is often used for men with prostate cancer that is found early and is slow-growing. (medlineplus.gov)
  • Mayo Clinic doctors and scientists are studying new ways to use brachytherapy to treat cancer. (mayoclinic.org)
  • Although medical opinion seems very supportive of brachytherapy with prostate cancer, often calling it an 'advanced treatment', it has to be said that this treatment is controversial, especially with breast cancer. (canceractive.com)
  • In prostate cancer , brachytherapy involves the ultrasound- and template-guided insertion of radioactive seeds into the gland. (medscape.com)
  • Brachytherapy for prostate cancer. (medscape.com)
  • In the 1970s, several centers used brachytherapy to treat prostate cancer. (medscape.com)
  • In the late 1980s and early 1990s, the emergence of transrectal ultrasonography (TRUS) and the development of template guidance led to the introduction of percutaneous brachytherapy for the treatment of localized prostate cancer. (medscape.com)
  • For appropriately selected patients, brachytherapy appears to offer cancer control comparable to that achieved with these other techniques. (medscape.com)
  • Of the 2000 sites performing radiation therapy, only about 650 perform brachytherapy, and not all of these handle breast cancer. (diagnosticimaging.com)
  • To evaluate outcome in patients with Gleason 7 prostate cancer treated with iodine-125 brachytherapy at the British Columbia Cancer Agency. (urotoday.com)
  • Prostate Cancer Institute of Arizona takes us through the fascinating journey of Steven StClair's diagnosis and treatment of his prostate cancer with LDR Brachytherapy by Dr. Ajay Bhatnagar. (aztv.com)
  • Depending on the kind of cancer and it's location in the patient's body, brachytherapy may be a favorable option when tumors cannot be surgically removed. (globehealer.com)
  • Brachytherapy is a form of radiation therapy used to treat cancer. (globehealer.com)
  • Brachytherapy, also referred to as internal radiation, is a form of radiation therapy used to treat prostate cancer and other types of cancer. (urologylosangeles.com)
  • Patients may receive brachytherapy on its own or in combination with other cancer treatments. (urologylosangeles.com)
  • How is MRI Brachytherapy Used to Treat Prostate Cancer? (urologylosangeles.com)
  • Plus, brachytherapy has been shown to help prostate cancer patients reduce the risk of impotence and incontinence that are commonly associated with radical prostatectomy. (urologylosangeles.com)
  • At Comprehensive Urology in Los Angeles, our urologists are happy to teach prostate cancer patients about all aspects of brachytherapy. (urologylosangeles.com)
  • Stefan Carl recently published a long-term evaluation of low-dose-rate (LDR) brachytherapy as a treatment option for localized prostate cancer. (ezag.com)
  • The study and findings paint a clear picture of the potential that LDR brachytherapy has in treating patients with prostate cancer. (ezag.com)
  • Brachytherapy, which involves implanting beads of radioactive material, is an "important treatment for genitourinary cancers," but it carries a long-term risk of sexual dysfunction, noted lead author Jamie Takayesu, MD, a radiation oncology resident at the University of Michigan Rogel Cancer Center in Ann Arbor, Michigan. (medscape.com)
  • However, when her team examined the records of over 200 patients who underwent brachytherapy for cervical or prostate cancer at their institution, they found that women were seldom asked about their sexual health. (medscape.com)
  • Speaking at a press briefing held during the meeting, Takayesu said: "I think this is something that most clinicians already know, that women are significantly less likely to be asked about their sexual health prior to receiving brachytherapy for cancer. (medscape.com)
  • For these reasons, most clinicians will see a reduction in the amount of time needed to complete these treatments, often by as much as an hour and a half," said Tim Clark, marketing manager for Varian BrachyTherapy. (varian.com)
  • The well established and clinically proven isotope for all HDR Brachytherapy treatments. (bebigmedical.com)
  • The global brachytherapy devices market is estimated to witness a massive growth rate of 8% from 2020 to 2030. (pharmiweb.com)
  • Brachytherapy is a form of radiation therapy where a sealed radiation source is placed inside or next to the area requiring treatment. (wikipedia.org)
  • The use of HDR brachytherapy enables overall treatment times to be reduced compared with EBRT. (wikipedia.org)
  • The authors reviewed the literature on the techniques, treatment protocols, and results of HDR brachytherapy in the treatment of carcinoma of the prostate, and they report their own protocols, technique, and results. (medscape.com)
  • Treatment options include radical prostatectomy and radiation therapy (external-beam and brachytherapy), among others. (medscape.com)
  • Brachytherapy is radiation treatment that is given directly into your body. (hopkinsmedicine.org)
  • In temporary brachytherapy, implants are removed after the treatment has ended. (hopkinsmedicine.org)
  • Internal radiation therapy (brachytherapy) allows a higher dose of radiation in a smaller area than might be possible with external radiation treatment. (cancer.org)
  • Using the latest version of Vitesse, HDR brachytherapy treatment plans can be created in a real-time environment, using ultrasound images generated in the operating room rather than CT scans generated elsewhere. (varian.com)
  • People with CAD who have already undergone Percutaneous Coronary Intervention (PCI) treatment are often candidates for coronary brachytherapy. (vejthani.com)
  • Discover our imaging and treatment solutions for brachytherapy - and how they help you transform care delivery and optimize clinical operations. (siemens-healthineers.com)
  • Once the treatment planning is done, the patient receives brachytherapy in the treatment room. (siemens-healthineers.com)
  • One drawback of the standard brachytherapy workflow: Patients need to be transferred twice - between applicator placement, imaging, and treatment. (siemens-healthineers.com)
  • Also, brachytherapy results in fewer side effects and a shorter treatment time in comparison to external beam radiation. (urologylosangeles.com)
  • Also, brachytherapy devices may be used during treatment, and a patient may require anesthesia or sedation to reduce discomfort. (urologylosangeles.com)
  • He and his colleagues conducted a retrospective multicenter analysis of LDR brachytherapy treatment in Germany. (ezag.com)
  • Best low-cost and yet high-quality Brachytherapy treatment in Greece for medical tourism patients. (2015medicaltourism.com)
  • Brachytherapy instead involves the precise placement of short-range radiation-sources (radioisotopes, iodine-125 or caesium-131 for instance) directly at the site of the cancerous tumour. (wikipedia.org)
  • Brachytherapy is commonly used to treat cancers of the cervix, prostate, breast, and skin. (wikipedia.org)
  • Which cancers may be treated with brachytherapy? (canceractive.com)
  • The side effects from brachytherapy for prostate cancers are typically temporary and decrease as the body becomes used to the seed implants. (uky.edu)
  • The 2 main ways radiation therapy can be used to treat skin cancers are external radiation therapy and brachytherapy. (cancer.org)
  • Interest in brachytherapy waned in the early 1980s because of these results, the advent of more advanced external beam radiation therapy (EBRT) equipment, and the development of the nerve-sparing radical prostatectomy. (medscape.com)
  • Brachytherapy is typically more precise than traditional external beam radiation and usually results in fewer side effects. (globehealer.com)
  • Brachytherapy takes 30 minutes or more, depending on the type of therapy you have. (medlineplus.gov)
  • Brachytherapy has fewer complications and side effects than standard radiation therapy. (medlineplus.gov)
  • Brachytherapy lets your doctor use a higher total dose of radiation over a shorter time than is possible with external beam therapy. (hopkinsmedicine.org)
  • https://www.rtanswers.org/How-does-radiation-therapy-work/Brachytherapy. (mayoclinic.org)
  • Brachytherapy candidates with a significant risk of extraprostatic extension should be treated with supplemental intensity-modulated radiation therapy. (medscape.com)
  • Throughout my first year on staff, she spent countless hours coaching me on how to manage patients through intensive courses of chemoradiation therapy and MRI-guided brachytherapy. (americanbrachytherapy.org)
  • Radiation therapy called brachytherapy keeps your arteries open by preventing scar tissue growth. (vejthani.com)
  • Vascular brachytherapy (VBT), cardiac brachytherapy, and adjunctive intracoronary radiation therapy are further names for coronary brachytherapy. (vejthani.com)
  • Many brachytherapy procedures are performed on an outpatient basis. (wikipedia.org)
  • In permanent brachytherapy, radiation sources are injected into or nearby the cancerous cells. (globehealer.com)
  • Generally, you will be treated on an outpatient basis when you have brachytherapy. (hopkinsmedicine.org)
  • Brachytherapy can be done on an outpatient basis for the gynaecological area and does not require any surgery. (amethyst-radiotherapy.ro)
  • If the brachytherapy implant is a low dose implant, it may be left in for several days. (hopkinsmedicine.org)
  • The length of time an implant is left in place depends on the type of brachytherapy you are getting. (cancer.org)
  • Axxent, with capital costs averaging one-tenth of those for either conventional brachytherapy or a linear accelerator, might be installed in communities where neither of these other options exist. (diagnosticimaging.com)
  • Internal radiation is also called brachytherapy . (cancer.org)
  • In our institute, an original brachytherapy technique based on the use of a molded applicator for genital tract brachytherapy has been applied routinely in clinical practice. (nih.gov)
  • Her passion for medicine, astute clinical skills, expert technical brachytherapy skills, drive for innovative research, dedication to medical education, and leadership as a woman in medicine modeled the foundation for my career, and her legacy continues to inspire my future aspirations. (americanbrachytherapy.org)
  • Research indicates that coronary brachytherapy can provide favorable long-term results for individuals with complex restenosis. (vejthani.com)
  • After brachytherapy, prostate-specific antigen (PSA) levels should be measured and a digital rectal examination (DRE) should be performed every 3-6 months for 5 years and yearly thereafter. (medscape.com)
  • North America holds the largest share in the brachytherapy devices market. (pharmiweb.com)
  • Compare international Radiology hospitals and ask about the total cost of the Brachytherapy medical services in Greece. (2015medicaltourism.com)
  • Brachytherapy can be used alone or in combination with other therapies such as surgery, EBRT and chemotherapy. (wikipedia.org)
  • These characteristics of brachytherapy provide advantages over EBRT - the tumour can be treated with very high doses of localised radiation whilst reducing the probability of unnecessary damage to surrounding healthy tissues. (wikipedia.org)
  • Men received EBRT, brachytherapy (monotherapy or boost) or prostatectomy as initial definitive management. (uwo.ca)
  • To our knowledge, this is the first report of increasing brachytherapy use in the era of dose escalated EBRT. (uwo.ca)